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Tiivistelmä
Unipolygrafiatutkimus on unihäiriödiagnostiikan referenssimenetelmä. Se on vaativa, työläs ja
monikanavainen rekisteröintimenetelmä, jossa uni- ja valveaika voidaan erottaa toisistaan
aivosähkökäyrässä, silmänliikekäyrässä ja lihassähkökäyrässä esiintyvien löydösten perusteella.
Rekisteröinti suoritetaan useimmiten valvottuna ja etenkin hengityshäiriödiagnostiikkaa tuke-
vien lisälaitteiden kera, joten se vaatii potilaan yöpymisen unilaboratoriossa. Suomessa on pitkät
perinteet unipatjojen käytöstä unitutkimuksissa etenkin hengitys- ja liikehäiriödiagnostiikassa.
Vanhat, jäykät, sängynkokoiset SCSB-patjat voidaan nykyään korvata pienemmillä, notkeilla
Emfit-filmistä valmistetuilla patjasensoreilla. Nämä reaaliaikaiseen liike- ja kohtausseurantaan
tarkoitetut patjat soveltuvat myös hyvin hengityksen monitorointiin unenaikana. Emfit-sensoria
ei ole kuitenkaan vielä tähän mennessä validoitu kliiniseen käyttöön sopivaksi diagnostiikan
apuvälineeksi.
Unenaikaiset hengityshäiriöt ovat yleisiä, nukkumista häiritseviä ja erialaisia väsymysoireita
aiheuttavia terveysongelmia aikuisväestön keskuudessa. Niiden diagnosointi ja hoito kuormit-
tavat terveydenhuoltoa enemmän kuin koskaan. Obstruktivinen uniapnea (OSA) ja siihen liitty-
vät terveyshaitat kuten sydän- ja verisuonisairaudet osataan nykyään tunnistaa varsin hyvin.
Yleensä uniapnean hoitoa suositellaan kun hengityskatkoja on keskimäärin yli 15 tapahtumaa
nukuttua tuntia kohti. Pitkäkestoinen osittainen ylähengitystieahtauma on jäänyt vähemmälle
huomiolle. Siinä unitutkimuksissa ei havaita hengityskatkoja tai periodista hengitystä eikä tois-
tuvia havahtumisia, jotka määrittävät yleisesti hengityshäiriön vaikeusasteen. Se saattaakin jää-
dä diagnosoimatta ja hoitamatta, vaikka potilasryhmällä on todettu päiväaikaisia oireita, kuten
päiväaikaista väsymystä, päänsärkyä ja masennusoireita.  Hengityshäiriödiagnostiikassa tulisi-
kin keskittyä ylähengitysteiden toimintahäiriön laadun määritykseen erilaisten indeksien sijaan.
Tässä väitöskirjatyössä Emfit-rekisteröintiä käytettiin periodisten hengityskatkojen ja pitkit-
tyneen osittaisen ylähengitysahtauman havaitsemiseen. Tulosten perusteella Emfit-patjasignaa-
lista luokiteltu hengityskatkojen määrä korreloi hyvin tavanomaisen hengityskatkoanalyysin
kanssa. Lisäksi Emfit-patjasignaalista luokiteltuun pitkäkestoiseen osittaiseen ylähengitystieah-
taumaan liittyi selkeä rintakehän sisäisen negatiivisen paineen nousu, mikä osoitettiin yhtäaikai-
sella ruokatorven kautta tapahtuvalla painemittauksella. Sitä pidetään lisääntyneen hengitystyön
mittaamisen referenssimenetelmänä. Vaikka siis pitkäkestoinen osittainen ylähengitystieahtau-
ma ei välttämättä näy tavanomaisessa unitutkimuksessa, se aiheuttaa poikkeavia muutoksia uni-
patjarekisteröinnissä. Pitkäkestoista osittaista ylähengitystieahtaumaa ilman merkittävää uniap-
neaa todettiin 11%:lla tutkituista, kun selvitettiin retrospektiivisesti vuoden ajalta unilaboratori-
ossa tutkittavina olleiden potilaiden hengityshäiriön tyyppi. Pitkäkestoista osittaista ylähengitys-
ahtaumaa sairastavat potilaat olivat yhtä väsyneitä kuin uniapneapotilaat, mutta heidän elämän-
laatunsa oli huonompi mitattuna GHQ-12 kyselytutkimuksella. Nämä tulokset ja sydämen syke-
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vaihtelua mittaavan osatyön löydökset osoittavat että pitkittynyt ylähengitystieahtauma on
itsenäinen hengityshäiriö.
Koska helpoille ja halvoille unenaikaisten hengitys- ja liikehäiriöiden seulontamenetelmille on
kasvava tarve, niin väitöskirjassa tutkittiin myös trakeaäänen käyttömahdollisuutta hengitys-
häiriöiden analysoinnissa. Se osoittautui käyttökelpoiseksi periodisen hengityksen ja hengitys-
katkojen havaitsemisessa, mutta myös pitkittyneen ylähengitysahtauman erotusdiagnostiikassa.
Väitöskirjatyön päätavoitteena oli hengityshäiriödiagnostiikan kehittäminen ja parantaminen, ja
nimenomaan esitettyjen uusien diagnostiikkamenetelmien osalta niiden luotettavuuden arvioi-
minen lisääntyneen hengitystyön osoittamisessa. Unirekisteröintien analyysi perustuu vielä
pitkälti rekisteröintejä analysoivan lääkärin subjektiiviseen ja visuaaliseen arvioon. Emfit-
unipatjalla voidaan erotella unenaikaisia hengityshäiriöitä ja parannetaan myös niiden diag-
nostista tarkkuutta. Se on toiminnaltaan teknisesti varsin häiriötön, automaattinen, ei-kajoava,
eli untahäiritsemätön diagnostiikkamenetelmä, joka sopii mainiosti myös kotona tapahtuviin
rekisteröinteihin. Se on kotimainen, edullinen ja soveltuu seulontatutkimusvälineeksi suurille
potilasjoukoille. Nykyisin terveysteknologiset biosignaalien mittaussovellukset ovat jokaisen
ulottuvilla ja käytettävissä älypuhelimilla tai tietokoneilla. Terveystietämyksen lisääntyminen
kannustaa meitä kaikkia seuraamaan ja ottamaan vastuun omista terveyteen vaikuttavista
tottumuksistamme jo paljon varhemmin ennen ongelmien esiintymistä. Hyvän unen tarve on
tunnustettu tosiasia hyvälle ja terveelle elämälle.
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Abstract
Sleep-disordered breathing (SDB) has become more common and puts more strain on public
health services than ever before. Obstructive sleep apnea (OSA) and its health consequences
such as different cardiovascular diseases are nowadays well recognized. In addition to OSA,
attention has recently been paid to another SDB; prolonged partial obstruction. However, it is
often undiagnosed and easily left untreated because of the low number of respiratory events
during polysomnography recording. This patient group has found to present with more atypical
subjective symptoms than OSA patients.
Polysomnography (PSG) is considered to be the gold standard in reference methods in SDB
diagnostics. PSG is a demanding and laborious multichannel recording method and often
requires subjects to spend one night in a sleep laboratory. There is long tradition in Finland to
use mattress sensors in SDB diagnostics. Recently, smaller electromechanical film transducer
(Emfit) mattresses have replaced the old Static Charge-Sensitive Bed (SCSB) mattresses.
However,  a  proper  clinical  validation  of  Emfit  mattresses  in  SDB  diagnostics  has  not  been
carried out.
In this work, the use of Emfit recording in the detection of sleep apneas, hypopneas, and pro-
longed partial obstruction with increased respiratory effort was evaluated. The general aim of
the thesis is to develop and improve the diagnostic methods for sleep-related breathing disorders.
Comparisons with both PSG with nasal pressure recording and transesophageal pressure were
made. Special attention was paid to the existence of the spiking phenomenon in the Emfit mat-
tress in relation to changes in negative intrathoracic pressure in estimating increased respiratory
effort. This entails monitoring the esophageal pressure as a part of nocturnal polysomnography.
The recording method is demanding and uncomfortable and is usually not used with ordinary
sleep laboratory patients. Thus, reliable and easy indirect quantification methods for respiratory
effort  are  needed  in  clinical  work.  According  to  the  results  presented  in  this  work,  the  Emfit
signal reveals increased respiratory effort as well as apneas/hypopneas.
To find out the prevalence and consequences of prolonged partial obstruction among sleep
laboratory patients was another aim of this thesis. This was done by retrospective analyses of
sleep laboratory patients from one year. The prevalence of patients with prolonged partial
obstruction was 11%. They were as sleepy as OSA patients, but their life quality was worse, as
assessed by a survey. These results, along with the findings of the heart rate variation evaluation
carried out in this thesis, suggest that prolonged partial obstruction and OSA should be
considered as different entities of SDB.
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With  the  Emfit  mattress  sensor,  the  SDB  types  can  be  differentiated,  which  is  expected  to
enhance  the  accuracy  of  diagnostics.  However,  there  is  increasing  need  for  easy  and  cheap
screening methods to evaluate nocturnal breathing. In this respect, the usability of compressed
tracheal sound signal scoring in SDB screening was estimated. The method reveals apneas and
hypopneas but, according to the present findings, it can also be used in the detection of
prolonged partial obstruction. The findings encourage the use of compressed tracheal sound
analysis in screening different SDB.
The analysis of sleep recordings is still based on a doctor’s subjective and visual estimation. To
date, no generally accepted and sufficiently reliable automatic analysis method exists. Robust,
automatic quantification methods with easier techniques for non-invasive sleep recording would
enable the analysis methods to be also used for screening purposes. In this technology-
orientated world, people could take much more responsibility and take care of themselves better
by following their own biosignals and by changing their health habits earlier. The need for good
sleep as a necessity for good life and health is widely recognized.
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11 Introduction
Sleep disorders have become more common, and puts more strain on public health services than
ever before. One major sleep disorder consists of repetitive respiratory events, apneas and
hypopneas, which are caused by obstruction of upper airways. These sleep-disordered breathing
abnormalities can lead to daytime symptoms, and is called the obstructive sleep apnea syndrome
(OSAS).  In  clinical  work  the  severity  of  OSAS  is  estimated  by  the  number  of  apneas  or
hypopneas per hour of sleep, the apnea hypopnea index (AHI). The health consequences of
OSAS, including various cardiovascular disorders such as hypertension, arrhythmias, coronary
artery disease even heart failure and stroke, are nowadays well-recognized. Sleepiness, the main
complaint of sleep-disordered breathing (SDB) patients, is thought to be explained mainly by
the respiratory effort-related arousals, which fragment the sleep process and often prohibits the
patient to enter deep sleep.  However, the mechanisms of OSAS related daytime symptoms are
not yet fully understood.
In addition to patients with a high AHI index and marked clinical symptoms, there are subjects
with prolonged partial upper airway obstruction. The low AHI value group (AHI <5/h and mild
OSAS AHI 5-15/h) may include patients with prolonged partial obstruction. Such patients are
often left undiagnosed and untreated. Upper airway obstruction is associated with increased
respiratory effort, which is considered to be its primary marker. The clinical significance of
prolonged partial obstruction is, however, still unclear. Nevertheless, according to clinical
practice, some of these patients clearly have similar symptoms to OSAS patients and many of
them would benefit from treatment. There are also findings that sustained partial obstruction is
associated with pathophysiological changes, for instance, elevated transcutaneously measured
carbon dioxide (Aittokallio et al., 2009, Rauhala et al., 2007, Rimpilä et al., 2014). Part of the
health consequences of SDB might be mediated by changes in the function of the autonomic
nervous system. This can be studied by the measurement and analysis of heart rate variability
(HRV).  It  has been shown that  OSAS is  associated with increased sympathetic  activity that  is
considered to reflect increased strain on the cardiovascular system and increased risk of vascular
co-morbidity. To date, knowledge of changes in HRV during prolonged partial obstruction is
lacking.  It  is  therefore  possible  that  all  SDB  disorders  are  important  health  problems,  that
decrease quality of life, and are associated with increased co-morbidity and mortality
(Anttalainen & Kalleinen, 2014, Anttalainen et al., 2010a, Marin et al., 2005, Young et al.,
2002).
Clinical polysomnography (PSG) is considered to be the gold standard and the reference method
of choice for sleep disorder diagnostics. It is, however, a laborious and rather expensive multi-
channel recording method and usually requires the patient to stay at least one night in the sleep
laboratory. Validated, reliable, and non-invasive clinical tools to detect prolonged partial ob-
struction with increased respiratory effort without arousals are few. In PSG, indirect effort quan-
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laboratory. Validated, reliable, and non-invasive clinical tools to detect prolonged partial ob-
struction with increased respiratory effort without arousals are few. In PSG, indirect effort quan-
2tification methods such as nasal pressure profile measurement are used. In the signal, the ob-
structed nasal airflow shapes are flattened instead of being the normal round shapes, indicating
flow limitation.
Partial upper airways obstruction with increased respiratory effort is associated with increased
negative pressure inside the chest. The reference method to estimate this increased intrathoracic
negative pressure is the measurement of transesophageal pressure with a pressure sensitive cath-
eter. Transesophageal pressure reflects pleural pressure. The measurement of prolonged partial
obstruction with a thick, water-filled catheter is a demanding procedure, but the use of new thin
catheters has made the measurements easier and more comfortable for the patient. The modern
measurement systems with thinner and smoother catheters are well-tolerated and do not disturb
the patient’s sleep in the same way as the older ones did (Oeverland et al., 2005a). However, the
recording of increased respiratory effort during sleep is still somewhat uncomfortable and labo-
rious when applied to every sleep laboratory patient.
In Finland, there is long tradition of diagnosing SDB and sleep-related movement disorders
using sleep mattress sensors (Alihanka et al., 1981). The original Static Charge-Sensitive Bed
(SCSB) mattress was first used for gross body movement detection during sleep. The workload
of the heart can be estimated by ballistocardiography (BCG). BCG is caused by the movement
of  the  heart  and  the  flow of  blood  from the  left  ventricle  to  the  aortic  artery.  By  filtering  and
amplifying the mattress signal, respiration can also be measured and periodic apnea/hypopnea
breathing can be detected (Alihanka et al., 1981, Polo, 1992). Increased respiratory workload
causes a so-called spiking phenomenon in the mattress signal (Kirjavainen et al., 1996).
In recent years, the large, the ElectroMechanical Film transducer (Emfit) has replaced the stiff
and expensive SCSB transducer. The Emfit was invented in Finland in the late 1980s, and it is
the first truly cellular polymer electret film available for commercial applications (Paajanen et
al., 2000). Sensors made from this film-type material were found to be useful especially in the
measurements of physiological pulsatile signals. Sensors constructed from commercial film
materials were soon recognized to be potentially suitable for non-invasive sleep research.
Although polyvinylidene fluoride (PVDF)  belts  and  Emfit  mattresses  are  used  in  sleep
recordings, there is a lack of clinical validation of these methods compared with PSG and other
methods used to detect SDB. Evidence is needed especially to find out, how reliable the Emfit
sensor is in measuring prolonged partial obstruction with increased respiratory effort, which is
considered to be the primary marker of upper airway obstruction.
In this work, the use of Emfit recording for the detection of sleep apneas, hypopneas, and pro-
longed partial obstruction with increased respiratory effort was evaluated. Comparisons both to
PSG with nasal pressure recording and transesophageal pressure were made. Special attention
was paid to the existence of the spiking phenomenon in the Emfit mattress in relation to changes
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3in negative intrathoracic pressure recorded by transesophageal catheter in estimating increased
respiratory effort.
In  some  of  the  subjects,  the  tracheal  sound  was  also  measured  to  find  out  its  usefulness  for
sleep-disordered breathing diagnostics.  In this part of the study, the spectral content of tracheal
sound in different sleep-disordered breathing patterns was analyzed in order to see whether dif-
ferent compressed tracheal sound signal patterns could be distinguished in different breathing
entities. These patterns were also compared to intrathoracic pressure measurement findings.
In order to study the effects of prolonged partial obstruction on the function of the autonomic
nervous system, HRV in relation to different breathing patterns was analyzed. The idea was to
evaluate whether prolonged partial obstruction would cause corresponding changes to autonom-
ic nervous system function as seen in obstructive sleep apnea (OSA). This would encourage
more studies on the possible health consequences of prolonged partial obstruction.
The analysis of sleep recordings is still based on somewhat subjective visual estimation. So far,
no generally accepted and sufficiently reliable automatic analysis method exists. Robust
automatic quantification methods with easier techniques for non-invasive sleep recording would
enable such methods to be also used for screening purposes. In this technology-orientated world,
people could take much more responsibility and take better care of themselves by following
their own biosignals and by changing their health habits earlier. Application of current and the
development of new easy-to-use and low-cost diagnostic methods could increase public health
and quality of life. As a result, SDB-associated co-morbidities could be avoided or at least
diminished. The need for good sleep as a necessity for good life and health has been widely
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42 Sleep-disordered breathing
Sleep-disordered breathing (SDB) comprises a broad spectrum of different respiratory symp-
toms. The mildest symptom in the spectrum is considered to be primary snoring without marked
upper airway obstruction. In the middle, is upper airway resistance syndrome (UARS) with
increased respiratory effort. At the most severe end of the spectrum is obstructive sleep apnea
syndrome (OSAS) with hypoxemia, hypercapnia, and sleep fragmentation (Guilleminault et al.,
1993).
2.1 Snoring
The snoring sound is  an inspiratory noise and results  from vibrations of  the soft  tissues of  the
pharynx, soft palate, and uvula. Increased snoring is often the first symptom that prompts pa-
tients to seek sleep examination. The prevalence of habitual, frequent snoring has been found to
be 10-60% (Lindberg et al., 1998b, Sporndly-Nees et al., 2014, Svensson et al., 2008). The
prevalence  is  higher  among  men  than  women  and  it  is  shown  to  increase  along  with  age
(Lindberg et al., 1998b, Sporndly-Nees et al., 2014).
Snoring can be considered to be a marker of increased respiratory effort (Bäck et al., 2002,
Ylikoski & Bäck, 2006). Snoring has been related to sleepiness (Gottlieb et al., 2000) and dif-
ferent morbidities such as hypertension, angina pectoris, and cerebral stroke (Koskenvuo et al.,
1985, Lindberg et al., 2007, Nieto et al., 2000). However, it is possible that these associations
are at least partly explained by the fact that snoring is usually connected to OSAS (Gottlieb et
al., 2000). The harmful effects of simple snoring without upper airway obstruction have re-
mained less clear. In fact, in one study no cardiovascular consequences related to simple snoring
were found (Marin et al., 2005). However, there is evidence that the vibration of snoring may
cause local nervous lesions to the muscles of the upper airway, which enables the airway to
collapse at inspiration (Friberg et al., 1998). Mechanical vibration can also induce injury to the
carotid arteries (Cho et al., 2011). In addition, snoring is related to sleepiness, work perfor-
mance problems, and traffic accidents, even in the absence of sleep apnea (Jackson et al., 2011,
Svensson et al., 2008, Ulfberg et al., 1996, Young et al., 1997a).
Obesity, smoking, nasal congestion, and physical inactivity have been found to be associated
with snoring as well as structural characteristics such as narrowness of the upper airway caused
by hypertrophy of the soft palate, palatal arch, and uvula (Koskenvuo et al., 1994, Lindberg et
al., 1998a, Sporndly-Nees et al., 2014, Young et al., 2002). Additionally, enlarged adenotonsil-
lar or a large tongue base may obstruct the upper airway (Pevernagie et al., 2010, Svensson et
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5al., 2006). The use of alcohol or sedative medication decreases the tonus of upper airway mus-
cles, and thus increases snoring (Bloom et al., 1988, Nagayoshi et al., 2011).
Occasional snoring is common. However, there is still uncertainty about how to define patho-
logical snoring. This causes difficulties in clinical practice because no clear guidelines exist
about the level of snoring that needs intervention. As a result, several different methods have
been developed in order to evaluate and quantify snoring. For example, the intensity of snoring
has been shown to increase with the severity of OSA (Maimon & Hanly, 2010), and the higher
acoustic intensity has been found to reflect more severe respiratory obstruction (Itasaka et al.,
1999, Lugaresi et al., 1983, Wilson et al., 1999). The spectral analysis of the snoring signal tak-
en  from  simple  snorers  has  been  used  in  differentiating  sleep  apnea  patients  (Agrawal  et  al.,
2002, Hill et al., 1999, Osborne et al., 1999, Perez-Padilla et al., 1993, Saunders et al., 2004). In
addition, different features of snoring epochs have been extracted in order to differentiate be-
tween normal and pathological snoring. It has been reported that when compared with simple
snorers, the snoring epochs of sleep apnea patients consist of more signal variability (Cavusoglu
et al., 2008, Sola-Soler et al., 2005). The treatment for snoring is often individualized, and in-
cludes conservative measures such as weight loss, alcohol and sedative avoidance, smoking
cessation, and sleep-position training. Active treatment methods for habitual snoring include
mandibular advancement appliances and nasal continuous positive airway pressure (CPAP)
treatment.  Even  the  surgical  intervention  of  the  soft  palate  has  been  used  if  sleep  apnea  and
other SDBs have  first been excluded (Tien & Kominsky, 2014).
2.2 Obstructive sleep apnea
Obstructive  sleep  apnea  (OSA)  is  characterized  by  repetitive,  total,  or  partial  closures  of  the
upper airway during sleep. The prevalence of OSA has been found to increase with age (Ancoli-
Israel et al., 1991) and it is higher among men than women. Among the adult population the
prevalence of sleep apnea has been reported to be 4% in men and 2% in women, but a higher
prevalence of up to 24% and 9% in men and women, respectively, has been reported (Gislason
et al., 1988, Punjabi, 2008, Young et al., 1993, Young et al., 1997b). According to a Finnish
questionnaire study, 8% of the general adult population may suffer from sleep apnea (Kronholm
et  al.,  2009),  and  a  Norwegian  study  reports  that  25% of  the  middle-aged  population   has  an
increased risk of developing OSA (Hrubos-Ström et al., 2011).
The  diagnosis  of  OSA  is  based  on  the  rules  established  by  the  American  Academy  of  Sleep
Medicine (Berry et al., 2012). The apnea is considered obstructive when polysomnography re-
veals episodes of no airflow with continuing inspiratory effort. According to the latest rules, the
respiratory event is classified as hypopnea when the reduction of airflow is 30% or greater and
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6lasts  for  at  least  10  seconds,  and  it  is  associated  with  an  arousal  or  at  least  a  3% reduction  in
oxygen saturation. Usually, the quantization of OSA is based on the apnea-hypopnea index
(AHI,  number  of  respiratory  events  per  hour  of  sleep)  calculated  from a  sleep  recording.  The
severity limits of AHI for adults are as follows: AHI < 5 (normal), 5 ≤ AHI < 15 (mild OSA),
15  ≤ AHI  <  30  (moderate  OSA),  and  AHI  ≥ 30  (severe  OSA), (American Sleep Disorders
Association, ASDA 1999).
Typical symptoms that OSA patients complain of are snoring, daytime sleepiness, memory and
mood problems, fragmented sleep, nocturia, decreased libido, and morning headaches (Epstein
et al., 2009, Krakow et al., 2001, Lavie, 2007, Park et al., 2011). In addition, OSA is known to
increase the number of traffic accidents (Young et al., 1997a). Women may report more atypical
symptoms related to OSA than men. These symptoms include insomnia, depression,
(Shepertycky et al., 2005), and morning fatigue (Ambrogetti et al., 1991).
Obesity  is  one  major  risk  factor  for  sleep  apnea  (Peppard  et  al.,  2000).  In  addition,  male  sex,
snoring, smoking, increasing age, and increasing neck circumference are all known to increase
the risk of sleep apnea (Fogelholm et al., 2007, Leger et al., 2012, Schwab, 1999, Wetter et al.,
1994, Young et al., 2002). Alcohol and muscle relaxants increase the risk by relaxing the mus-
cles in the upper airway (Al Lawati et al., 2009). It is known that female hormones may have an
impact on the neurologic control of the upper airway muscles. Indeed, the risk of OSA increases
in females after the menopause (Bixler et al., 2001).
Obstructive sleep apnea has been proven to be an independent risk factor for stroke and cardiac
disease (Canessa & Ferini-Strambi, 2011, McNicholas & Bonsigore, 2007). This may be ex-
plained by the repetitive oxygen desaturations and arousals, that are known to increase sympa-
thetic tone (Palma et al., 2013, Ringler et al., 1990), and, in addition to systematic inflammation
and oxidative stress, sympathetic tone might be one of the main predisposing factors for the
cardiovascular morbidity associated with OSA (McNicholas & Bonsigore, 2007).
The most effective treatment for OSA is CPAP. Overweight patients are encouraged to change
lifestyle and join weight-management programs. Bariatric surgery can be applied with very
obese patients. Other surgical procedures, like bipolar radiofrequency thermal ablation of the
soft palate and mandibular corrections  can be used in selective groups of patients (Kryger et al.,
2011).
2.3 Upper airway resistance syndrome
Guilleminault et al. first reported upper airway resistance syndrome (UARS) in 1993. Conven-
tionally, UARS represents a form of sleep-disordered breathing without apneas/hypopneas but
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7with repetitive increases in resistance to airflow leading to flow limitation and esophageal pres-
sure swings followed by brief respiratory effort-related arousals (RERAs) (Guilleminault et al.,
1993).  The prevalence of UARS was found to be 8.4% among academic military personnel at a
sleep disorder center (Kristo et al., 2005). The prevalence of UARS in the general population is
unknown, but it has been thought to be as common as sleep apnea (Pepin et al., 2012).
In the diagnosis of UARS, the quantification of arousals is essential, and therefore full poly-
somnography with electroencephalography (EEG) is needed. The progressive increase in respir-
atory effort related to RERAs can be estimated by measuring the esophageal pressure or another
respiratory effort parameter, for example, the changes in pulse transit time (Pepin et al., 2012).
UARS is defined by the occurrence of excessive daytime sleepiness unexplained by other caus-
es  (Pepin et  al.,  2012).   In  UARS, hypopneas and apneas are rare.  UARS is  found to be more
common in young and less overweight patients than OSA (Stoohs et al., 2008). Subjective
symptoms  such as mood disorders, decreased libido, and cognitive impairment, with changes in
attention, concentration, executive function, and fine-motor coordination are often present and
they may resemble the symptoms of OSA (Pepin et al., 2012). Insomnia and sleep quality com-
plaints are more frequent with UARS patients than with OSA patients (Stoohs et al., 2008).
Patients with UARS may suffer from anatomical nasal abnormalities or increased collapsibility
of  the upper  airway (Chen & Kushida, 2003, Gold et al., 2002). In addition, they may present
with long face, cross-bite, high-arched hard palate, and small mandible in back position
(Guilleminault et al., 2001b). An interesting finding is that patients with UARS often present
with hypotonia (Guilleminault et al., 2001b).
Even if  OSAS and UARS events  have been found to result  in  differences in HRV parameters
(Guilleminault et al., 2005), there has been and there still is a debate about the true existence of
UARS as a  specific  disorder (Douglas, 2000). The International Classification of Sleep Disor-
ders, ICSD3 (American Academy of Sleep Medicine, 2014) includes UARS as a part of OSA,
and it is not considered as a separate entity. Treatment of UARS comprises similar approaches
to those in OSA.
2.4 Prolonged partial upper airway obstruction
Increasing attention has been paid to prolonged partial upper airway obstruction during sleep. In
particular, Finnish sleep research has a long tradition of SCSB studies (Anttalainen et al., 2010b,
Anttalainen et al., 2006, Anttalainen et al., 2007a, Anttalainen et al., 2007b, Polo, 1992, Polo-
Kantola et al., 2003, Saaresranta et al., 2001). This phenomenon is assessed by sustained nega-
tive increase in esophageal pressure or by a prolonged flow limitation pattern in the nasal pres-
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8sure transducer signal (Bao & Guilleminault, 2004, Hernandez et al., 2001). Prolonged flow
limitation periods of up to several minutes have been found to be common findings in sleep
studies (Hernandez et al., 2001). During CPAP treatment, the prolonged partial obstruction ap-
pears if the treatment pressure is insufficient (Calero et al., 2006). Often, prolonged partial up-
per airway obstruction is considered to be a mild form of SDB, with no need for active treat-
ment as discussed previously (Anttalainen et al., 2013).
Prolonged partial obstruction is the most common type of SDB found in women, and in a clini-
cal setting it is found to be more frequent in women than in men (Anttalainen et al., 2007a,
Anttalainen et al., 2007b). Women with prolonged partial obstruction suffer from the same ex-
cessive daytime sleepiness as OSA patients (Anttalainen et al., 2013).
It is thought that the pathophysiology behind the prolonged partial obstruction is caused by ana-
tomical structural differences. Patients with prolonged partial obstruction have been found to
have narrower airways at tongue base level and hyoid bone level and more micrognathia than
OSA-patients (Anttalainen et al., 2013, Polo et al., 1991).
In SCSB-studies, prolonged partial obstruction and OSA-findings are often combined and the
symptoms, risk factors, and the consequences of pure prolonged partial obstruction have been
studied less. It has been reported that transcutaneous carbon dioxide tension (tcCO2) increases
cumulatively during prolonged partial obstruction, whereas during periodic breathing with ap-
neas and hypopneas no cumulative increase was obtained (Rauhala et al., 2007). The conse-
quences of the prolonged partial upper airway obstruction have been evaluated in one study,
where an association between asthma and chronic obstructive pulmonary disease (COPD) with
prolonged partial obstruction was found. In addition, that study pointed out that the prevalence
of hypertension was lower in women with prolonged partial obstruction compared with women
with OSA (Anttalainen et al., 2010b).
The symptoms and consequences as well as the risk factors of pure prolonged partial obstruc-
tion have been investigated only slightly. Although prolonged partial obstruction presents with a
similar non-apneic increase in negative esophageal pressure as seen in UARS, a recent review
considered prolonged partial obstruction and UARS to be different entities (Guilleminault et al.,
2001a, Pepin et al., 2012). However, it might also be that there is a lack of clarity in terms.
CPAP treatment  is  used in prolonged partial  obstruction,  and some surgical  procedures can be
useful. In addition, medications might be needed to relieve mood problems (Anttalainen et al.,
2013).
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93 Recommended sensors for detecting sleep-disordered
breathing
3.1 Scoring of sleep and associated events
Polysomnography (PSG), which includes the simultaneous recording of various physiologic
parameters, is the gold standard for diagnosing SDB. The differentiation between sleep and
wakefulness is performed by sleep staging electroencephalogram (EEG), along with eye move-
ments (electrooculogram, EOG), and submental muscle tension electrodes (electromyogram,
EMG).  The recommended derivations for EEG are F4-A1, F3-A1, C4-A1, C3-A2, O2-A1, and
O1-A2, where the primary electrode is placed above the brain area according international 10-
20 system, and the reference electrode is the contralateral mastoid. The EOGdx is placed 1 cm
above the right outer canthus and the EOGsin electrode 1 cm below the left outer canthus and
the reference electrode is the left mastoid for both (Iber et al., 2007). Using these signals, the
recording is categorized as Rapid Eye Movement (REM) and Non-REM (NREM) sleep. The
NREM category generally includes three stages of sleep: light sleep N1, N2, and deep sleep N3.
Usually, the quality of sleep is assessed by the amount of deep sleep. The number of arousals is
found  to  increase  and  the  amount  of  deep  sleep  decreases  in  sleep  apnea  (Saunamäki  et  al.,
2009). In UARS, arousals are frequent (Guilleminault et al., 1993).
Diagnosing sleep-disordered breathing requires the synchronized recording of respiration, cardi-
ac function, and body movements. For this, airflow, respiratory effort, snoring, electrocardio-
gram (ECG), oxygen saturation, leg movements, and body position are measured. Simultaneous
video monitoring is used to distinguish SDB from other sleep disorders.
3.2 Airflow sensors
During breathing, airflow is reduced during hypopneas and absent during apneas. The recom-
mended reference device for measuring respiratory airflow is the pneumotachograph. The
measurement principle is direct and the tidal volume can be quantitatively measured. However,
measuring the pneumotachograph signal requires a sealed facemask, that many find cumber-
some, and it is not routinely used in clinical sleep studies (Farre et al., 2004).
Thermistors and thermocouples are sensors whose electrical characteristics (resistance and volt-
age)  depend  on  their  temperature.  They  sense  differences  in  the  temperature  of  the  cooler  in-
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spiratory and warmer expiratory airflow when placed close to the airway, i.e. the nose or mouth.
These sensors do not have a linear relationship with the true airflow, and thus they are inaccu-
rate flow measuring devices. Their use for quantifying hypopneas may lead to considerable
under detection of the respiratory events (Ballester et al., 1998). The main limitations of these
thermal devices are that their dynamic response is poor because of slow response, which largely
depends on their exact position at the airway opening. Accordingly, thermistors and thermocou-
ples are not suitable to accurately quantify the magnitude of flow, but they are simple to use,
small in size, and well tolerated.
A nasal cannula placed in the nostrils and connected to a pressure transducer detects the pres-
sure fluctuations caused by inspiration and expiration, and thus indirectly measures airflow. A
airflow  turbulences  at  the  nostrils  induce  a  pressure  change  that  is  directly  related  to  airflow
magnitude. As compared to pneumotachograph, the nasal cannula has been shown to be a valid
tool for identifying apneas/hypopneas in clinical practice (Heitman et al., 2002, Thurnheer et al.,
2001). Because the nasal cannula slightly overestimates the number of hypopneas, square-root
linearization of the signal is recommended (Farre et al., 2001).
The nasal cannula has a rapid time-response that allows for a detailed analysis of the inspiratory
flow. If the sampling rate is high enough (at least 200 Hz), nasal prongs also provide infor-
mation on snoring and on the shape of the inspiratory flow waveform (Hernandez et al., 2001).
The flow waveform is modulated by the collapsibility of the upper airway wall (Series & Marc,
1999). A round flow shape is observed during a regular, normal inspiratory phase of the breath-
ing cycle. A flattened, non-round flow shape (flow limitation) is present during partial obstruc-
tion. Signal loss can happen due to the obstruction of the cannula by secretion, displacement of
the cannula, narrowness of the nostrils, or a deviated septum (Lorino et al., 1998). The potential
drawback of the nasal cannula is that it does not detect mouth breathing.
Although a pressure transducer has been found to be more sensitive than thermocouples in de-
tecting AHI (Hernandez et al., 2001), the thermal airflow sensor is recommend in the identifica-
tion of an apnea using the AASM 2.0 (Berry et al., 2012). For hypopnea detection, the nasal
pressure transducer with or without linearization is recommended.
3.3 Measuring respiratory effort
As a consequence of an obstruction of the upper airway, a patient with obstructive SDB exerts
increased inspiratory efforts in an attempt to maintain ventilation. The gold standard signal to
quantitatively  assess  the  inspiratory  effort  is  esophageal  pressure  measurement  (pESO).  It  de-
tects changes in pleural pressure produced by the work of the inspiratory muscles and requires
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the use of an invasive esophageal balloon or catheter (Mead & Gaensler, 1959, Milic-Emili.J et
al., 1964). The trans-nasal insertion of the pressure catheter is often considered uncomfortable.
Therefore, the technique is mostly used for research purposes only and in clinical work indirect,
noninvasive methods have replaced esophageal measurement. During inspiration the pleural
pressure  normally  varies  from  -5  cmH2O  to  -7.5  cmH2O (Guyton & Hall, 2006). There is no
absolute esophageal pressure level that is known to be abnormal (AASM, (Berry et al., 2012).
During periodic apnea/hypopnea breathing, a crescendo- type pattern of negative inspiratory
pressure can vary between -13 and -35 cmH2O. The pressure values are found to be lowest just
after the relief of occlusion. In severe OSA, pressure values under - 40 cmH2O have been meas-
ured. In UARS, deep pESO increases can also be obtained (Guilleminault et al., 1993).
Belt sensors can be used to measure inspiratory effort non-invasively. The method that is based
on the use of two bands, one placed around the thorax and another placed around the abdomen,
is called inductive plethysmography. Each band includes an inductive coil whose electromag-
netic properties depend on the thoracic and abdominal cross-sectional areas. The changes in the
cross-sectional areas provide an indirect method to measure respiratory effort. This technique is
simple to use, and it does not interfere with the patient’s sleep. However, the volume changes do
not reflect muscle activity when upper airway impedance changes. The disadvantage of the belts
is  that  the method requires  calibration (pneumotachograph or  spirometer),  which has to be re-
peated if there is displacement of the bands or posture changes during the registration period
(Chokroverty, 1994, Farre et al., 2004).
Another non-invasive method to assess respiratory effort is to measure the surface electromyog-
raphy  (EMG)  of  respiratory  muscles.  Diaphragmatic  EMG  has  been  shown  to  reflect  relative
changes in respiratory effort during sleep and it is used instead of esophageal manometry
(Knaack  et  al.,  2005).  However,  the  use  of  diaphragm or  parasternal  EMG is  limited  because
reliable recordings are often difficult to obtain (Chokroverty, 1994). In clinical work the respira-
tory muscle EMG recordings are often used in children’s PSGs only.
3.4 Snoring
The AASM recommendation for monitoring snoring is to use an acoustic sensor (e.g. micro-
phone), piezo-electric sensor or nasal pressure transducer. The sampling rate should be high
enough, 500 Hz desirable and 200 Hz minimal, (AASM, Berry et al., 2012) for accurate detec-
tion of the amplitude variation of snoring. If the preprocessing of snoring results in a continuous
sound level or in a sound intensity level, AASM recommendations allow lower sampling rates.
Many commercial programs analyze snoring using an envelope technique with a certain preset
threshold value, and give a snoring index as a time percentage for total sleep time. However, no
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reference values for a snoring index exist. The acoustic analysis of the snoring sound spectrum
has been developed in order to find a more accurate and objective way to evaluate the snoring
site  and  source  and  its  treatment  (Dalmasso  &  Prota,  1996,  Fiz  et  al.,  1996,  Moerman  et  al.,
2002). In OSA and UARS, snoring is frequent but intermittent (Pepin et al., 2012). In prolonged
partial obstruction, snoring is often continuous, but valid studies are lacking.
3.5 ECG and HRV analysis
The electrocardiogram (ECG) is recorded to detect respiratory-related heart rate changes during
sleep. According to AASM recommendations (Berry et al., 2012), bipolar electrodes should be
placed with slight modification of electrocardiograph Lead II (leads between the lower left rib
cage  and  the  right  clavicula  notch).  Additional  leads  may  be  used  if  clinically  indicated,  but
often the current nocturnal evaluation is limited to rough estimations of arrhythmias from one
channel. The beat-to-beat heart rate recording and simple statistics of heart rate variability
(HRV) is a generally recognized approach for assessing autonomous nervous system activity.
The spectrum of heart rate variability is usually analyzed in different frequency bands: the low
frequency band (LF), 0.04-0.15 Hz, which corresponds to 10-s variation and refers to a cumula-
tive variation of sympathetic and parasympathetic components, and the high frequency band
(HF), 0.15-0.4 Hz, which corresponding to fast variations almost exclusively containing the
parasympathetic component of heart rate. Thus, the ratio between LF/HF allows us to obtain the
sympathetic index correlated to heart rate changes. The very low frequency band (VLF), 0.003-
0.04 Hz, is thought to reflect slow regulatory mechanisms such as the renin-angiotensin system
and thermoregulatory processes and is possibly mediated by the sympathetic system  (American
Heart Association, 1996).
A lot of basic research has been done that, for example, has studied the effects of sleep cycles,
sleep stages, and OSA on the autonomous nervous system (Penzel et al., 2003, Penzel et al.,
2002, Stein & Pu, 2012). In OSA, an increase in sympathetic activity is well documented
(Somers et al., 1995). HRV studies of UARS are, however, sparse and HRV during increased
respiratory resistance has not been evaluated.
3.6 Pulse oximetry
Finger oximetry is the most common method for monitoring arterial oxygen saturation (SaO2).
The measurement principle of pulse oximetry is based on the different red and infrared light
absorption of oxyhemoglobin and deoxyhemoglobin (Yoshiya et al., 1980). Light absorption in
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blood is usually measured with transmission technique. The arterial oxyhemoglobin saturation
reflects the percentage of oxygenated hemoglobin. The sensor should be fixed carefully on a
translucent site with good blood flow. The method is especially sensitive to a patient’s move-
ments, which may lead to severe motion artifact. Light absorption due to arterial pulsation can
be used to calculate heart rate. The heart rate value is averaged and does not exactly represent
the beat-to-beat rate. The maximum acceptable signal averaging time is three seconds according
to AASM recommendations (Berry et al., 2012). According to the current guidelines, oxygen
desaturation is used to define the hypopnea events. This strengthens the need for the continuous,
good quality monitoring of SaO2 in sleep studies.
Non-conventional sensors in SDB diagnostics
3.7  Tracheal sound
Tracheal breathing sounds are usually collected using a microphone placed on the suprasternal
notch. The use of other recording sites such as lateral neck and more than one site has been in-
vestigated (Kaniusas et al., 2005, Krumpe & Cummiskey, 1980). Higher sampling rates are
more commonly used than in snoring detection because obstruction of the upper airway has
been found to increase the number of high signal frequencies over 200 Hz (Fiz et al., 1999,
Herzog et al., 2008, Kaniusas et al., 2005, Michael et al., 2008, Pasterkamp & Sanchez, 1992,
Rao et al., 1990, Yonemaru et al., 1993). Usually respiratory sounds are divided into different
frequency bands. The low frequency band (under 100 Hz), where heart and thoracic muscle
sounds overlap, is usually filtered and omitted in analyses. The middle frequency band (200–
600 Hz) and the high frequency band (600–1200 Hz) comprise the major frequency components
of tracheal breathing sounds (Gavriely et al., 1981, Pasterkamp et al., 1997).
A snoring sound is considered as part of the respiratory sounds (Pasterkamp et al., 1997,
Sovijärvi et al., 2000). Indeed, many studies concentrate on the analysis of snoring using trache-
al sound (Cummiskey et al., 1982, Peirick & Shepard, Jr., 1983). In addition, tracheal sound
measuring methods have been developed to detect OSA in both adults and children (Beckerman
et al., 1982, Cummiskey et al., 1982, Krumpe & Cummiskey, 1980, Kulkas et al., 2009, Nakano
et al., 2004, Sanna et al., 1991). In one preliminary work, the data compression of tracheal
sound was used in the screening of SDB. The data compression revealed three distinct sound
patterns: plain, thick, and thin. The plain sound pattern would indicate normal breathing, the
thick sound pattern was found to be associated with periodic apneas and hypopneas, and the thin
sound pattern might be associated with prolonged flow limitation (Rauhala et al., 2008). Also,
the development of portable respiratory sound screening devices has been carried out because
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the need for a simple and reliable means of diagnosing OSA and other SDB has increased (East
& East, 1985, Hida et al., 1988, Lugaresi et al., 1983).
3.8 Mattress sensors
Static charge-sensitive bed, (SCSB)
Many researches, especially in Scandinavia, have utilized the static charge-sensitive bed (SCSB)
in diagnostics of SDB (Anttalainen et al., 2010b, Anttalainen et al., 2006, Anttalainen et al.,
2007a, Anttalainen et al., 2007b, Erkinjuntti et al., 1984, Lojander et al., 1998, Saaresranta et al.,
2001, Salmi & Leinonen, 1986, Salmi et al., 1986, Svanborg et al., 1990). Jukka Alihanka and
Kaarlo Vaahtoranta from the Department of Physiology at Turku University developed the
SCSB (Figure 1) in the late 1970s for the long-term monitoring of sleep movements. The SCSB
is a non-invasive sensor that is placed under a normal foam mattress to detect a sleeper’s gross
body movements, breathing, and heart beats without any electrodes being attached to the subject
(Alihanka et al., 1981, Polo, 1992, Polo et al., 1989, Polo et al., 1988, Polo et al., 1993, Polo et
al., 1992). The charge of the sensor is modified when static charge layers of the mattress move
in conjunction with the sleeper’s body movements. The movements induce potential differences,
which can be measured with a differential AC amplifier.
Nocturnal breathing induces alternations in the SCSB signal. In the diagnostics of SDB, three
different  SCSB signal  channels  are  usually used.  In the early years,  the 0.2 -  40 Hz band was
utilized in the detection of gross body movements. Respiratory movements were achieved from
the low frequency band (0.2 - 1 Hz), and the ballistocardiography (BCG) signal (4 - 40 Hz) was
used to monitor the workload of the heart and reveal high frequency spiking. Using the three
channels mentioned above, the signal was visually scored into normal breathing (NB), four dif-
ferent types of periodic breathing (P1, OP1, OP2, OP3), and increased respiratory resistance
(IRR) pattern in three-minute epochs.
The suitability of SCSB in OSA diagnostics has been evaluated and it has been shown to identi-
fy obstructive apneas with high sensitivity (Polo et al., 1988). The OP3 pattern was suggested to
consist of obstructive apneas, whereas the other periodic breathing categories comprised more
hypopneas (Polo et al., 1989, Polo et al., 1988). IRR was reported to be a constant phenomenon
without periodic breathing variation. Instead, prominent continuous high frequency spikes
emerged during IRR. The high frequency spikes were considered to be episodes of prolonged
partial obstruction and were often associated with constant heavy snoring.
The origin of the high frequency spikes were a matter of debate until Kirjavainen with his co-
workers (Kirjavainen et al., 1996) reported that during experimental respiratory challenging,
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channels mentioned above, the signal was visually scored into normal breathing (NB), four dif-
ferent types of periodic breathing (P1, OP1, OP2, OP3), and increased respiratory resistance
(IRR) pattern in three-minute epochs.
The suitability of SCSB in OSA diagnostics has been evaluated and it has been shown to identi-
fy obstructive apneas with high sensitivity (Polo et al., 1988). The OP3 pattern was suggested to
consist of obstructive apneas, whereas the other periodic breathing categories comprised more
hypopneas (Polo et al., 1989, Polo et al., 1988). IRR was reported to be a constant phenomenon
without periodic breathing variation. Instead, prominent continuous high frequency spikes
emerged during IRR. The high frequency spikes were considered to be episodes of prolonged
partial obstruction and were often associated with constant heavy snoring.
The origin of the high frequency spikes were a matter of debate until Kirjavainen with his co-
workers (Kirjavainen et al., 1996) reported that during experimental respiratory challenging,
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healthy, awake adults produced spiking when respiratory efforts became stronger. These spikes
have a close time-link to respiratory movements (onset of either inspiration or expiration) rather
than heart movements. In this way, the emergence of spikes would reflect increased respiratory
effort and, can be detected non-invasively instead of using the esophageal catheter.
Electromechanical film transducer, Emfit
The electromechanical film transducer (Emfit) is commonly used as an access control system in
old people’s homes, in seizure monitoring, and in vital signs monitoring (Van et al., 2013). In
sleep studies, the Emfit mattress has been in use since 1997. As compared to SCSB, the Emfit
mattress  is  small,  easy to handle and quite  inexpensive.  In sleep studies,  the Emfit  mattress  is
placed under the normal foam mattress and under the thoracic area of the patient (Figure 1).
Usually, the Emfit mattress is connected to a PSG device as an external sensor through a signal
monitor box. Alametsä with co-workers have evaluated the Emfit sensor and found it to be suit-
able and reliable for BCG and pulsewave measurements (Alametsä et al., 2009). The Emfit
sheet is very sensitive, and even periodic leg movements can be detected with the mattress
placed under the thoracic area of the sleeper (Alametsä et al., 2006, Rauhala et al., 2009).
Emfit sheet is an elastic, permanently charged polypropylene ferro-electret film that responds to
mechanical stress. It is composed of thin polymer layers that are separated by air voids. When
an external force is applied on the film, orthogonal mechanical pressure changes the thickness
of these air voids more than the stiff permanently charged layers. As a result, the Emfit signal
mainly arises from the movement of the permanently charged polymer layers with respect to the
internal layers, and are called "quasi-piezoelectric” as the charge is not produced by direct pres-
sure changes but is proportional to the change in force (Paajanen et al., 2000, Rajala & Lekkala,
2010). The sensor operation has a capacitive nature and it is mainly based on thickness varia-
tions caused by an external force in the middle of the film.
Generated change of output voltage can be calculated as
ΔV = (1/C) x Sq x ΔF,
where ΔF = change of impact force acting on the film, C = total capacitance [pF] and  Sq = sen-
sitivity coefficient [25-250 pC/N] of the Emfit sensor.
The sensitivity of the Emfit material is very high vertical to mattress surface, but very small
(1 % of vertical) in horizontal directions. So the impact of stretching of the film is very small
(Rajala & Lekkala, 2012). The voltage signal can also be monitored and linked to different digi-
tal signal acquisition systems.
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In SDB diagnostics,  according to the established practice,  the raw Emfit  signal  is  filtered into
two different frequency bands. The low-frequency band (0.3–10 Hz) shows breathing move-
ments, and the high frequency band (6–16 Hz) reveals movements related to heart activity as
well as high frequency spikes (Alametsä et al., 2006, Polo et al., 1988). The gross body move-
ments are seen on the raw data channel. The Emfit breathing categories are visually scored by
these three channels, as in SCSB scoring. However, the detailed evaluation of the different
breathing categories as well as the comparison of the breathing categories to the conventional
sleep parameter is lacking.
Figure 1. The blue Emfit- mattress on top of the traditional SCSB-mattress (coated silver foil).
In clinical use, they both are placed under a normal foam mattress.
A polyvinylidene fluoride (PVDF) piezoelectric transducer can also be used as a sleep mattress.
PVDF is a semicrystalline polymer, which has a solid and homogenous structure compared with
cellular  Emfit.  The  PVDF generates  measurable  voltage  when  deformed  and  it  also  reacts  for
lateral stretching. The capability of PVDF to measure heart and respiration rate has been com-
pared with Emfit film with good correlation (Kärki et al., 2007, Kärki & Lekkala, 2008, Kärki
& Lekkala, 2009). Quite recently, the PVDF-based device Sonomat (Sonomedical Pty Ltd,
Balmain, NSW Australia) for SDB diagnostics has been introduced (Norman et al., 2014). The
Sonomat is able to detect breathing movements and airflow in the form of breath sounds. The
correlation of the AHI detected by Sonomat when compared with conventional PSG has been
found to be good.
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4 Aims of the thesis
The main aim of the present study was to develop and improve the analysis methods of different
SDB by
1. Evaluating the capability of the Emfit mattress to detect increased respiratory effort dur-
ing sleep.
2. Validating the Emfit mattress in OSA diagnostics.
3. Evaluating the prevalence and consequences of prolonged partial obstruction.
4. Evaluating prolonged partial obstruction with tracheal sound.
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5 Materials and Methods
The polysomnographies of Studies I-V were performed in the Sleep Laboratory of the Depart-
ment of Clinical Neurophysiology at Tampere University Hospital. The Ethical Committee of
the Pirkanmaa Hospital District approved Studies I, II, IV and V. The medical director of Tam-
pere University Hospital approved the protocol of Study III, as in retrospective analyses in gen-
eral.  In  every  study,  the  subjects  gave  their  written  informed  consent  to  participate.  Specific
methods for each study are presented in their respective sections.
5.1 Subjects
Study I – Tracheal sound
Thirty-six consecutive patients (30 male, 6 female) referred to the Sleep Laboratory volunteered
to participate in this study. Two patients were examined because of suspected narcolepsy, one
because of the suspicion of restless leg syndrome, and the others were suspected to have SDB.
The demographic data and sleep parameters of the patients are presented in Table 1.
Sleep is  quantified using numerous parameters.  The scored time for  each sleep stage as  a  per-
centage of total score time (%S1-S4, %SREM) is reported to provide an estimation of the distri-
bution of the sleep stages through the night. Sleep is entered through the non-REM sleep stage
that normally constitutes around 75-80% of sleep. Each sleep cycle ends to REM sleep stage,
constituting 20-25% of sleep. SWS (slow wave sleep stages S3+S4, nowadays combined to the
N3 stage) predominates in the first third of the night and is linked to sleep onset and the length
of the time spent awake. REM sleep predominates in the last third of the night and is linked to
the circadian rhythm of body temperature. Good sleep is very individual but often comprises 4-6
sleep cycles and around 10-15% of stage 4 sleep. Most young adults report sleeping around 7.5-
8.5 hours (total sleep time TST). People who sleep for less than 5 hours are short sleepers and
people who sleep for more than 10 hours are long sleepers. The other sleep quality parameters
are the sleep efficiency index (SEI normal if > 85%), which is calculated as the ratio of TST to
time in bed (TIB), sleep latency (SL normal if < 15 min), which means bedtime, duration of
time  from lights  off  to  the  onset  of  sleep,  and  REM sleep  latency,  which  is  the  interval  from
sleep onset to the first appearance of the REM sleep stage (REMlat varied around 90 min). The
level of breathing problem is estimated with indices calculated from the occurrences of respira-
tory events such as hypopneas, apneas, arousals, and desaturations (AHI, ARI, and ODI4),
which are calculated per hour of total sleep time. The periodicity of limb or leg movements are
estimated  with  the  PLMI  index,  which  is  the  calculated  number  of  PLMs  per  hour  of  sleep.
PLMI > 15 determines clinical significance, but the finding should be adjusted to other findings
in PSG.
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Table 1. Sleep parameters and demographic data of the 36 subjects in Study I.
Median Min Max
Age (years) 45 16 68
BMI1 (kg/m2) 27.3 21.8 44.6
TST2 (h) 6.7 3.7 8.8
SEI3 (%) 84.0 65.5 99.0
SL4 (min) 9.0 0.0 53.5
REMlat5 (min) 119.0 1.5 223.5
%S16 9.4 1.9 39.6
%S27 66.3 49.5 86.8
%S38 6.1 0.0 17.7
%S49 0.2 0.0 21.3
%SREM10 15.4 0.4 25.5
ARI11 (n/h) 41.9 10.9 108.1
AHI12 (n/h) 19.3 0.4 91.2
ODI413 (n/h) 6.8 0.3 95.3
1Body mass index
2Total sleep time
3Sleep efficiency index
4Sleep latency
5Latency to REM (rapid eye movement) sleep
6-10 Percentage of sleep stage (S1-SREM) referred to TST
11Arousal index = number of cortical arousals per hour of TST
12Apnea-hypopnea index = apneas and hypopneas per hour of TST
13Oxygen desaturation index = number of desaturations > 4% per
hour of TST
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Study II – Emfit and esophageal pressure (pESO)
A total  of  32  patients  (27  males,  5  females)  with  suspected  SDB volunteered  to  participate  in
Study II. The sleep parameters and the demographic data of the patients are presented in Table 2.
Table 2. Sleep parameters of the 32 patients.
Median Min Max
Age (years) 43 25 60
BMI1 (kg/m2) 30.5 22.2 53.9
TIB2 (h) 8.0 5.3 10.4
TST3 (h) 6.7 3.9 9.0
SEI4 (%) 81.4 65.3 95.1
SL5 (min) 16.8 1.0 67.0
REMlat6 (min) 160.5 44.0 372.0
%N17 8.7 2.5 35.1
%N28 65.5 41.3 80.5
%N39 9.2 0.6 39.9
%REM10 14.9 0.0 24.1
ARI11 (n/h) 24.4 6.5 82.6
AHI12 (n/h) 16.0 1.5 105.7
ODI413 (n/h) 6.0 0.7 86.7
SaO2min14 (%) 87.0 75.0 94.0
PLMI15 (n/h) 1.0 0.0 43.0
1Body mass index
2Time in bed
3Total sleep time
4Sleep efficiency index
5Sleep latency
6Latency to REM (rapid eye movement) sleep
7-10 Percentage of sleep stage referred to TST
11Arousal index=number of cortical arousals per hour of TST
12Apnea-hypopnea index=apneas and hypopneas per hour of TST
13Oxygen desaturation index=number of desaturations > 4% per
hour of TST
14Minimum of oxygen saturation
15Periodic limb movement index
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Study III – retrospective Emfit
The polysomnographies of adult patients (>18 years) that were recorded between 03/2005–
03/2006 in the Sleep Laboratory of Tampere University Hospital were evaluated retrospectively.
The total number of PSGs was 189. Due to technical problems with some sensors, 32 recordings
were excluded. Therefore 157 patients (97 male and 60 female) were included in the further
studies. The reasons for referral were hypersomnia (66/157), SDB (40/157), insomnia (28/157),
CPAP control (9/157), parasomnia (6/157), and others (8/157). The demographic data and the
PSG parameters of the patients are presented in Table 3.
Table 3. Demographic and PSG data of the 157 subjects in Study III.
Median Min Max
Age (years) 47 18 71
BMI1(kg/m2) 27 16 45
ESS2 10 0 22
GHQ-123 3 0 12
SST4 (h) 6.3 0.0 10.0
TST5 (h) 6.8 3.1 10.0
TIB6 (min) 8.3 5.9 10.7
SEI7 (%) 84.0 39.0 98.0
SL8 (min) 16.0 0.0 151.5
REMlat9 (min) 124.0 1.5 543.0
%N110 7.2 0.1 54.4
%N211 66.1 39.8 88.7
%N312 7.3 0.0 45
%REM13 14.4 0.3 31.2
ARI14 (n/h) 18.3 5.8 97.7
AHI15 (n/h) 9.7 0.1 93.8
AI16 (n/h) 1.1 0.0 85.3
ODI417 (n/h) 2.0 0.0 81.0
SaO2min18 (%) 88.0 53.0 96.0
Pulse (bpm) 60.4 40.1 96.0
PLMI 19 (n/h) 4.5 0.0 145.9
1Body mass index, 2Epworth sleepiness scale, 312-item General Health
Questionnaire, 4Subjective sleep time, 5Total sleep time, 6Time in bed,
7Sleep efficiency index, 8Sleep latency,9Latency to REM (rapid eye
movement) sleep, 10-13Amount of sleep stage referred to TST, 14Arousal
index, 15Apnea-hypopnea index; 16Apnea index, 17Oxygen desaturation
index, number of desaturations > 4% per hour of TST, 18Minimum per-
centage of oxygen saturation, 19Periodic limb movement index
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Study IV – Emfit and HRV
Fifty-three subjects (37 male, 16 female), referred to the Sleep Laboratory because of suspected
SDB. The exclusion criteria were as follows: cardiac arrhythmias, pacemaker or ischemia, car-
diomyopathy, history of neurological or pulmonological diseases, diabetes, and drugs known to
impair the function of the autonomic nervous system. Forty-four out of the 53 patients had OSA
(AHI > 5/h). Fifty-one patients had at least one 3-minute periodic obstructive breathing (POB)-
epoch, 47 patients had at least one IRR-epoch, and 51 had one or more NB-epochs. The sleep
parameters of the patients are presented in Table 4.
Table 4. Sleep parameters of the 53 patients in Study IV.
Median Min Max
Age (years) 45 25 68
BMI1 (kg/m2) 29.7 20.1 53.9
TIB2 (h) 8.2 5.8 10.7
TST3 (h) 6.8 3.7 9.8
SEI4 (%) 85.9 47.8 97.1
SL5 (min) 15.5 1.0 74.5
REMlat6 (min) 138.0 44.0 466.5
%N17 7.2 0.1 40.6
%N28 65.5 41.3 86.8
%N39 9.7 0.0 45.0
%REM10 15.0 0.0 24.1
ARI11 (n/h) 20.7 0.5 59.2
AHI12 (n/h) 11.0 1.5 88.0
ODI413 (n/h) 4.0 0.1 63.0
SaO2min 14(%) 87.0 66.0 93.0
PLMI 15 (n/h) 3.7 0.5 42.0
1Body mass index, 2Time in bed, 3Total sleep time, 4Sleep
efficiency index = TST/TIB, 5Sleep latency, 6Latency to
REM (rapid eye movement) sleep,
7-10Percentage of sleep stage (N1-REM) referred to TST,
11Arousal index, number of cortical arousals per hour of
TST, 12Apnea-hypopnea index, apneas and hypopneas per
hour of TST, 13Oxygen desaturation index, number of
desaturations > 4% per hour of TST, 14Minimum of oxy-
gen saturation, 15Periodic limb movement index
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Study V – Compressed tracheal sound
Twenty-seven consecutive patients (22 male, 5 female) referred to the Sleep Laboratory due to
the suspicion of  SDB volunteered to participate  in  this  study.  The sleep data  derived from the
sleep recordings of the 27 subjects are shown in Table 5.
Table 5. Demographic data and sleep parameters of the 27 subjects in Study V.
Median Min Max
Age (years) 42 28 58
BMI1 (kg/m2) 30.0 22.2 53.9
TST2 (h) 6.7 3.9 9.4
SEI3 (%) 81.7 65.3 95.1
SL4 (min) 15.5 1.0 67.0
REMlat5 (min) 171.0 44.0 372.0
%N16 9.8 2.5 35.1
%N27 64.6 41.3 80.5
%N38 11.1 0.8 39.9
%REM9 14.6 0.0 24.1
ARI10 (n/h) 22.8 6.5 59.2
AHI11 (n/h) 13.9 1.5 88.0
ODI412 (n/h) 6.0 0.7 63.0
%SaO2min13 86.5 77.0 94.0
%SaO2mean14 94.0 90.9 96.5
1Body mass index
2Total sleep time
3Sleep efficiency index, 4Sleep latency
5Latency to REM (rapid eye movement) sleep
6-9Percentage of sleep stage (N1-REM) referred to TST
10Arousal index, number of cortical arousals per hour of TST
11Apnea-hypopnea index, apneas and hypopneas per hour of TST,
12Oxygen desaturation index, number of desaturations > 4%  per hour of TST
13Minimum oxygen desaturation
14Mean oxygen desaturation
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5.2 Instrumentation and analysis
5.2.1 Recording montages
The Embla N7000 device (Embla®, Natus Medical inc., USA) and Somnologica Studio software
(Medcare®, Flaga, Reykjavik, Iceland) were utilized in all studies. The PSG recordings consist-
ed of six or eight EEG derivations (Fp1-M2, Fp2-M1, C3-M2, C4-M1, O1-M2, O2-M1 or Fp1-
M2, Fp2-M1, F3-M2, F4-M1, C3-M2, C4-M1, O1-M2, O2-M1), two EOG channels (EOGdx
and EOGsin), three electromyogram channels (chin and both legs), airflow with a thermistor
and a nasal pressure transducer, thoracic and abdominal respiratory movements with inductive
belts, pulse and oxygen saturation by an integrated pulseoximeter (Nonin Medical Inc, USA),
position sensor, and electrocardiogram (ECG) electrodes. Also, video signal was recorded in
every study. A sampling rate of 2 Hz was used for the pulse oximetry (SpO2 and pulse rate), 10
Hz for respiratory movements, 500 Hz for ECG, and 200 Hz for the other signals.
5.2.2 Emfit recordings
In all studies, the Emfit mattress (32 cm x 62 x 0.4 cm, Emfit Ltd, Finland) was placed under a
normal foam mattress below the thoracic area of the sleeping subject. The Emfit mattress was
connected to a PSG device with touch proof connectors through an electronic monitor. The un-
filtered Emfit signal was acquired directly as a separate trace in the Somnologica software with
a sampling rate  of  200 Hz.  When the patient  lies  on the mattress,  the sensor  produces a  small
voltage signal that ranges from a few microvolts to a few volts depending on the force of
movement.
5.2.3 Tracheal sound measurement
The tracheal sound recordings in studies I and V were performed with an electret microphone
(Panasonic WM-60A, Matsushita Electric Industrial Co, Ltd, Kadoma Osaka, Japan). The sensi-
tivity of the microphone was 10 mV/Pa and the frequency range in the free field was 20 Hz - 20
kHz, + 2 dB (Sovijärvi et al., 1998). The microphone was attached to the skin in the suprasternal
notch as presented in previous studies (Kulkas et al., 2010, Rauhala et al., 2008). The tracheal
sound signal was amplified and high-pass filtered with a cut-off frequency of 50 Hz and fed into
a Sound Blaster Audigy 2 NX sound card (Creative Labs, Singapore) for a 24-bit A/D conver-
sion. The galvanic isolation between the patient and the recording device was handled with an
USI-01 isolator (MESO, Mittweida, Germany). The raw sound signal from the sound card was
converted into Embla data format and synchronized with PSG signals at a sampling rate of
11025 Hz. Somnologica Studio software (Medcare®, Flaga, Reykjavik, Iceland) was used for
the visual analysis of the signal.
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5.2.4 Esophageal pressure measurement
The esophageal pressure measurements in studies II, IV and V were performed with the Reggie
(Camtech AS, Norway) commercial pressure-monitoring device presented in Figure 2. The
pressure catheter is made of soft silicon and is 1.9 mm in diameter. The pressure transducer
consists of a diaphragm covering a Wheatstone bridge, which is part of the electrical circuit able
to change the electrical resistance according to the tension of the bridge. The tension changes
result in changes in the signal voltage. The signal was calibrated, giving a numerical pressure
value in cmH2O units. The catheter contained five pressure sensors; the upmost sensor is situat-
ed in the nasal cavity and the others at the epipharynx, oropharynx, and hypopharynx. The prox-
imal sensor in the esophagus was situated 15 cm distally from the hypopharynx-sensor. Special
software was developed in order  to  import  the pESO signal  to  the Somnologica software.  The
sampling rate for the Reggie signal was 10 Hz. A patient with extended full PSG equipment is
shown in Figure 2.
Figure 2. On the left the Reggie esophageal manometry device with the esophageal catheter
(green one), oximeter probe (white wire) and actimeter (grey wire). On the right a picture of a
patient with full PSG equipment. The figure is published with permission of the patient.
In the Reggie device, the esophageal pressure value -8 cmH2O is considered to be the cut-off
value between obstructive and non-obstructive breathing (Oeverland et al., 2005b). This thresh-
old is commonly used both in clinical practice and in scientific work, and therefore it was em-
ployed in the present studies.
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5.3 Analysis of polysomnographies
5.3.1 Conventional sleep parameters
The  recordings  in  studies  I  and  II  were  scored  into  sleep  stages  according  to  the  criteria  of
Rechtschaffen  and  Kales  (Rechtschaffen  & Kales,  1968).  In  studies  III-V  the  rules  by  AASM
were utilized (Iber et al., 2007). The same rules were applied in the classification of the respira-
tory events. For hypopneas rule 4b was used, which means amplitude diminutions ≥ 50% of
airflow with additional criterion of concomitant arousal or desaturation of ≥ 3% (Iber et al.,
2007). An AHI index was calculated as the number of apneas and hypopneas per hour, and
arousals  were  scored  according  to  the  criteria  of  the  American  Sleep  Disorders  Association
(ASDA, 1992).
5.3.2  Scoring of the Emfit signal (Studies II, III, IV)
The raw Emfit signal, which shows gross body movements, was filtered into two additional
channels with band-pass of 0.3-10 Hz (low frequency channel, LF) and 6-16 Hz (high frequency
channel, HF). The LF channel visualizes respiratory movements and the HF channel discloses
heart-related movements and respiratory related spikes (Kirjavainen et al., 1996). These three
channels were used in the visual scoring of the Emfit signal into different Emfit breathing cate-
gories. Two independent scores performed the scoring in 3-minute epochs from a lights off-
event to the final awakening, and their consensus scoring was used in the analyses. The scoring
principles are slightly modified from the former SCSB rules (Polo et al., 1992). The breathing
categories used were normal breathing (NB), periodic breathing (P1), obstructive periodic
breathing, types 1, 2, and 3 (OP1, OP2, OP3), increased respiratory resistance (IRR), and central
periodic breathing (CPB). Epochs with large movements that lasted for more than 40 seconds
were classified as movement epochs (M), and epochs with several short periodic movements
without respiratory variation were scored as periodic movement (PM) epochs. In studies III and
IV, the periodic obstructive breathing categories (OP1, OP2, and OP3) were combined to form
one periodic obstructive breathing category (POB).  The scoring rules are presented in Table 6
and examples of the stages are given in Figure 3a, b, c, and d.
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Table 6. Characteristics of mattress breathing categories (scoring rules).
Breathing movements
in LF channel (0.3-10 Hz)
High frequency spikes
in HF (6-16 Hz) channel
Gross body movements
in the raw Emfit signal
NB Regular No No
P1 Periodic amplitude variation No No
OP1 Periodic amplitude variation Periodic/ intermittent No
OP2 Periodic amplitude variation Periodic/intermittent Present between ap-neas/hypopneas
OP3 Periodic amplitude variation Periodic/intermittent Present between ap-neas/hypopneas
CPB
No movements during apnea,
periodic movements between
apneas
May be present between
apneas May be present between apneas
IRR Regular Continuous No
M May vary Artifact Prolonged (duration > 40s)
PM Regular No Periodic; more than 3 short(< 10s) movements per epoch
LF=Low frequency Emfit-signal power band 0.3-10 Hz, HF=High frequency Emfit-signal power
band 6-16 Hz, NB=normal breathing, P1=periodic breathing type1,OP1=obstructive periodic breath-
ing type1, OP2 =obstructive periodic breathing type 2, OP3 =obstructive periodic breathing type
3,CPB =central periodic breathing, IRR = increased respiratory resistance, M = movement,PM =
periodic movement
Normal breathing (NB)
Emfit
LF
HF
RAW
pESO
Flow
NB: regular respiratory movements in LF and HF signal bands, no body movements
(Raw Emfit signal). pESO above –5 cmH2O. Round flow shapes in linearized nasal
pressure channel (Flow).
Figure 3a. Example of normal breathing category with pESO and flow signal (3-min interval).
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Periodic Type 1, P1
Emfit
LF
HF
RAW
pESO
Flow
P1: Periodic amplitude variation in LF band. No spikes in HF band. No body move-
ments. pESO above -8 cmH2O, slight variation. Non-round and round flow shapes in
flow channel.
Obstructive Periodic Type 1, OP1
Emfit
LF
HF
RAW
pESO
Flow
OP1: Periodic amplitude variation in LF band. Intermittent spikes in HF band. No
body movements. pESO decrease up  to -15 cmH2O between events. Hypopneas with
non-round flow shape in flow channel.
Figure 3b. Examples of P1 and OP1 Emfit breathing categories. Hypopneas events are marked
with yellow background in flow channel.
28
Periodic Type 1, P1
Emfit
LF
HF
RAW
pESO
Flow
P1: Periodic amplitude variation in LF band. No spikes in HF band. No body move-
ments. pESO above -8 cmH2O, slight variation. Non-round and round flow shapes in
flow channel.
Obstructive Periodic Type 1, OP1
Emfit
LF
HF
RAW
pESO
Flow
OP1: Periodic amplitude variation in LF band. Intermittent spikes in HF band. No
body movements. pESO decrease up  to -15 cmH2O between events. Hypopneas with
non-round flow shape in flow channel.
Figure 3b. Examples of P1 and OP1 Emfit breathing categories. Hypopneas events are marked
with yellow background in flow channel.
29
Obstructive Periodic Type 2, OP2
Emfit
LF
HF
RAW
pESO
Flow
OP2: Periodic amplitude variation in LF band. Large respiratory related spikes in HF
band. Body movements in raw trace. pESO decrease up to -20 cmH2O between
breathing events. Hypopneas and apneas with non-round shape in flow channel.
Obstructive Periodic Type 3, OP3
Emfit
LF
HF
RAW
pESO
Flow
OP3: Large periodic amplitude variation in LF band. Crescendo-type spikes in HF
band. Body movements in raw signal trace. pESO swinging from -10 cmH2O to -30
cmH2O. Hypopneas and apneas with non-round flow shapes in flow channel.
Figure 3c. Examples of obstructive OP2 and OP3 Emfit breathing categories. Obstructive apnea
events are marked with red and hypopneas with yellow background in flow channel.
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Obstructive Periodic Type 2, OP2
Emfit
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RAW
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Flow
OP2: Periodic amplitude variation in LF band. Large respiratory related spikes in HF
band. Body movements in raw trace. pESO decrease up to -20 cmH2O between
breathing events. Hypopneas and apneas with non-round shape in flow channel.
Obstructive Periodic Type 3, OP3
Emfit
LF
HF
RAW
pESO
Flow
OP3: Large periodic amplitude variation in LF band. Crescendo-type spikes in HF
band. Body movements in raw signal trace. pESO swinging from -10 cmH2O to -30
cmH2O. Hypopneas and apneas with non-round flow shapes in flow channel.
Figure 3c. Examples of obstructive OP2 and OP3 Emfit breathing categories. Obstructive apnea
events are marked with red and hypopneas with yellow background in flow channel.
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Increased Respiratory Resistance, IRR
Emfit
LF
HF
RAW
pESO
Flow
IRR: Regular respiratory in LF band, some amplitude increase. Continuous spiking in
HF band. No body movements. Sustained pESO decrease from -15cmH2O to -
25cmH2O. Non-round flow shape in flow channel.
Figure 3d. Example of IRR Emfit breathing category. The Emfit signal is presented as raw
channel with low frequency band pass (LF 0.3-10 Hz) and high frequency range (HF 6-16 Hz).
Esophageal pressure (pESO) values range from +10 to -30 cmH2O. Airflow is calculated from
the nasal pressure transducer (Flow).
5.3.3 Scoring of the tracheal sound in the Study V
The tracheal sound data was overviewed by compressing the signal data, as presented previous-
ly (Rauhala et al., 2008). In the reduction procedure only the maximum and minimum sound
signal values of each consecutive 15-s epoch were taken. This compressed sound information
(four maximum and minimum samples per minute) was used in the visual analyses in study V.
The compressed tracheal sound signal was scored into four different categories: a plain signal
curve close to zero, a thin signal curve deviating clearly from zero and a thick, highly varying
signal curve. The fourth category comprised signal periods of low quality, which were omitted
from the analyses.Examples of the compressed tracheal sound patterns are presented in Figure 4.
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Figure 4. Compressed tracheal sound curve of an OSA patient (AHI 75/h). The 10-minute long
plain, thick and thin patterns are indicated with black rectangles. The arbitrary unit of amplitude
is denoted as ‘au’.
5.4 Detailed methods of the Studies
Study I
Three different 10-minute long breathing epochs were selected from the nasal flow channel of
each patient. The periodic breathing pattern was selected if repetitive apneas or hypopneas were
present during the epoch. The other breathing epochs were selected based on the shape of the
inspiratory flow curve, and therefore the inspirations with a round flow shape were visually
distinguished from the non-round, flow-limited inspirations. During normal breathing, 80% or
more of the inspirations had to be round shaped. During the prolonged flow limitation epochs,
80% or more of the inspirations had to be non-round. Only epochs during NREM-sleep were
taken into account.
To explore the tracheal sound spectrum of the different breathing epochs, the raw sound signal
was spectral analyzed with one-second segmenting. After the mean removal, each signal seg-
ment was weighted with a Hanning window function of respective length. No zero padding was
used, and hence the frequency resolution of the spectrum was 1 Hz. The discrete Fourier trans-
form (DFT)  was  performed  to  provide  the  complex-valued  spectrum,  which  was  scaled  to  the
corresponding amplitude spectrum as presented previously (Huupponen et al., 2008).
The overall spectral content during the selected epochs was calculated by The Welch estimate of
the amplitude spectrum using 50% overlapping. From the Welch spectrum the average ampli-
tude in the total  frequency range of  50-5512 Hz,  as  well  as  in  narrower frequency bands were
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determined. In addition, the percentage-proportions of the sound amplitudes in the low, middle,
and high frequency bands (50-100 Hz, 101-600 Hz, 601-5512 Hz) were extracted for each
epoch.
Study II
In study II, the number of different polysomnographic events as well as the esophageal pressure
variations in different Emfit breathing categories during NREM sleep were studied. To achieve
this, one 3-minute epoch of every Emfit breathing category (whenever present) was selected
from each patient. The number of respiratory events, arousals, and desaturations during the 3-
minute breathing epochs were calculated visually.
The proportion of time (referred to TST) with pESO values £ -8 cmH20 in both 3-minute Emfit
epochs and in the different Emfit categories of the whole night was calculated automatically. In
addition, the most negative pESO values within the 3-minute epochs were extracted automati-
cally.
Study III
Demographic data of the 157 patients were collected from the questionnaires routinely in use in
the Sleep Laboratory. The data comprised age, sex, BMI, reason for referral, end-diagnosis,
score of  the Epworth Sleepiness  Scale (Goldberg et  al.,  1997,  Johns,  1991),  subjective time in
sleep, and medications.
The Emfit respiratory scoring results were correlated to AHI, and the Emfit category with the
best correlation with AHI was used in further analyses. The simple linear regression was used to
fit a straight line to estimate the time percentage of impaired breathing by the Emfit sensor that
corresponds to the AHI-values of 5/h, 15/h, and 30/h. The obtained percentage values were used
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Study IV
The  parameters  of  heart  rate  variability  (HRV)  were  calculated  from the  three  different  Emfit
breathing categories (NB, POB, IRR) in study IV. The esophageal pressure signal was used to
confirm increased respiratory effort during the POB and IRR epochs.
The mean HRV values of all at least 6-minute periods of NB, POB, and IRR were first calculat-
ed and then averaged over categories. The RR-intervals were extracted from the ECG signal by
using an adaptive QRS detection algorithm to recognize R-peaks. The HRV calculations were
carried out using Kubios HRV analysis software (Tarvainen et al., 2014). The standard devia-
tion (SDNN), mean (mean RR) as well as minimum and maximum of normal- to-normal RR
intervals (RRmin, RRmax) were calculated for each breathing category. The frequency domain
parameters  of  heart  rate  variability  were  analyzed  in  three  frequency  bands:  the  very  low fre-
quency band (VLF, 0.003-0.04 Hz), the low frequency band (LF, 0.04-0.15 Hz), and the high
frequency band (HF, 0.15-0.4 Hz). In addition, the LF/HF –ratio was calculated.
Study V
One 10-minute representative episode of plain, thin and thick compressed tracheal sound pattern
from each subject (see Figure 4), whenever present, was selected for further analyses. Two re-
searchers confirmed this selection.
The percentage of the time (referred to total sleep time) when the pESO values were below -8
cmH2O was calculated automatically for each selected 10-minute compressed sound pattern and
for each patient if existing. The spectral analyses were performed as in study I with frequency
bands of 50-1000 Hz, 1001-2000 Hz, 2001-3000 Hz, 3001-4000 Hz, and 4001-5512 Hz for each
10-minute episode.
5.5 Statistics
Statistical analyses were performed with SPSS® for Windows versions 16.0 and 17.0 (SPSS
Inc.) in studies I-II and IBM® SPSS® Statistics versions 20.0 and 21.0 (IBM corp.) in studies
(III-V). Non-parametric tests were used because all variables were not normally distributed. The
Friedman test was used to estimate if multiple dependent variables varied by tested category.
The Wilcoxon signed-rank test with appropriate Bonferroni corrections was used in post hoc
analyses (studies I, II, IV, V). The p-values < 0.05 were considered as significant in the statisti-
cal tests.
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In  Study  III,  the  Spearman’s  correlation  coefficient  was  computed  to  assess  the  relationship
between Emfit scoring and the AHI. Based on AHI level 15/h, a receiver operating characteris-
tic (ROC) curve was derived and an area under the curve (AUC) was calculated. The sensitivi-
ties and specificities were computed using standard formulae. The two patient groups were
compared with the Mann-Whitney test.
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6 Results
6.1 Capability of the Emfit mattress to detect respiratory effort
during sleep (Study II)
Intrathoracic pressure variations during the Emfit breathing categories were evaluated in study
II. Normal breathing pattern (NB) was identified in 29/32 patients, P1 pattern was present in 30
patients, OP1 pattern in 31 patients, OP2 pattern in 26, OP3 pattern in 14, and IRR pattern in 24
patients. NB with periodic movements (PM) covered 18.6% (median, range 0.0-72.3%) of TST.
The number of other breathing categories as median percentage of TST were consecutively: P1
14.2% (0.0-39.4%), OP1 34.5% (0.6-72.4%), OP2 2.9% (0.0-30.9%), OP3 0.0% (0.0-16.7%),
and IRR 3.8% (0.0-19.7%). Gross body movements (M) covered 4.9% of TST (0.0-36.7%).
The proportion of time (referred to TST) with increased respiratory effort (pESO values £ -8
cmH20) during the different Emfit breathing categories were calculated within 3-minute epochs
and from the overnight sleep period (Table 7). In the 3-minute epochs, respiratory effort re-
mained low in NB-epochs when compared with OP1, OP2, OP3, and IRR (p = 0.006, 0.009,
0.033 and 0.002, respectively). Respiratory effort was increased in IRR-epochs when compared
with P1, OP1, and OP2 (p = 0.002, 0.001, and 0.023, respectively). Respiratory effort was also
lower in P1-epochs when compared with OP3 (p = 0.033).
The most negative esophageal pressure values (pESOmin) in 3-minute epochs are presented in
Table 7. The pESOmin value of NB was higher than the values of P1, OP1, OP2, OP3, and IRR
(p = 0.011, 0.001, 0.004, 0.043, and 0.003, respectively). In addition, pESOmin in P1 was high-
er than pESOmin values of OP2, OP3, and IRR (p = 0.043, 0.033, 0.005, respectively).
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Table 7. The proportion of time with increased respiratory effort (pESO £ -8  cmH20, median
value with range) and the minimum value of pESO in different breathing categories.
Emfit
category 3-minute representative epochs
Overnight
Emfit recording
pESO values
£ -8 cmH20 (%) pESOmin (cmH2O)
pESO values
£ -8 cmH20 (%)
NB 0.0 (0.0-4.0) -8 (-4  to -16) 1.9 (0.0-26.3)
P1 0.7  (0.0-22.5) -12 (-5 to -23) 2.6 (0.0-25.9)
OP1 3.7 (0.0-28.3) -16 (-4 to -35) 6.4 (0.0-24.4)
OP2 7.7 (0.0-26.1) -16 (-7 to -41) 8.0 (0.2-25.3)
OP3 15.3 (0.7-30.9) -26 (-13 to -42) 13.1(1.1-27.5)
IRR 23.5(0.1-36.1) -21 (-9 to -41) 18.7 (0.0-44.2)
NB normal breathing, P1, OP1, OP2, OP3 different forms of periodic breathing, and IRR
increased respiratory resistance. Median values with ranges are presented.
Figure 5 presents the overnight proportion results when pESO £ -8 cmH20 with p-values in Em-
fit breathing categories. Respiratory effort increased during OP1, OP3, and IRR when compared
with NB. In addition, effort was high during IRR when compared with P1, OP1, and OP2. Ef-
fort remained low during P1 when compared with OP1 and OP3. The rest of the comparisons
did not reach statistical significance.
Figure 5. Percentage proportion with increased respiratory effort (pESO values ≤ -8 cmH2O) in
Emfit scoring categories during the overnight sleep.
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6.2 Validation of the Emfit mattress in OSA diagnostics
6.2.1 Respiratory events, arousals and desaturations in 3-minute epochs of the dif-
ferent Emfit breathing categories, Study II
The number of respiratory events (apneas + hypopneas), arousals, and desaturations (³ 4%) in
the representative 3-minute Emfit breathing epochs of Study II are presented in Figure 6. Ap-
neas or hypopneas were present in P1 and OP-epochs but not found in NB or IRR-epochs. The
statistically significant differences between breathing categories are presented in Figure 6, and
all p-values are p< 0.049.
The smallest number of arousals occurred during NB and IRR, with no statistical difference.
Arousals were abundant during OP1- and OP2- epochs when compared with NB- epochs (p-
values 0.002 and 0.001, respectively). More arousals were found in P1 (p = 0.003), OP1 (p =
0.0003), OP2 (p = 0.001), and OP3 (p = 0.047) when compared with IRR-epochs. P1 consisted
of a lower number of arousals than OP2 (p = 0.007).
No desaturations were present in NB or IRR epochs. In other breathing categories, desaturations
were  found,  but  the  only  significant  differences  were  obtained  between  IRR  vs.  OP1  (p  =
0.014), IRR vs. OP2 (p = 0.014), NB vs. OP2 (p = 0.014), and P1 vs. OP2 (p = 0.006).
Figure 6. Different events in representative 3-minutes epochs during the Emfit breathing cate-
gories. The statistically significant differences are marked with lines.
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6.2.2 Correlation between AHI and Emfit breathing categories, Study III
The Emfit respiratory scoring results were correlated to AHI in Study III. The correlation coef-
ficients are presented in Table 8. NB-pattern presented marked negative correlation with AHI (-
0.806). The highest positive correlation (0.891) was found between AHI and the combined OP
patterns (= OP1 + OP2 + OP3). Therefore, a POB-category (POB = OP1% + OP2% + OP3%)
was used in further analyses.
Table 8. Spearman´s correlation coefficients between AHI index and different Emfit breathing
combinations. Correlations with statistical significance are marked with an asterisk. The highest
Emfit correlation with AHI is marked in bold.
Emfit breathing category Correlation with AHI
NB% -.806*
P1% -.105
OP1% .865*
OP2% .558*
OP3% .499*
IRR% .248*
OP1+OP2% .888*
OP2+OP3% .596*
OP1+OP3% .872*
P1+OP1% .777*
P1+OP2% .270*
P1+OP3% .113
P1+OP1+OP2% .828*
P1+OP2+OP3% .790*
P1+OP1+OP2+OP3% .790*
OP1+OP2+OP3% .891*
OP1+OP2+OP3+IRR% .849*
P1+ OP1+OP2+OP3% .835*
P1+ OP1+OP2+OP3+IRR% .824*
AHI = apnea-hypopnea index,
NB = normal breathing,
P1 = periodic breathing type 1,
OP = obstructive periodic breathing type 1-3,
IRR = increased respiratory resistance
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The POB percentages corresponding to the selected AHI cut-off values were extracted from the
regression  analysis  between  the  AHI  and  POB%  (Figure  7).  The  selected  AHI  cut-off  values
were 5/h, 15/h, and 30/h and corresponding POB percentages turned out to be 9%, 21% and
39%, respectively.
Figure 7. Scatter  plot  of  the correlation between the AHI and the percentage of  time spent  in
POB-patterns (OP1%+OP2%+OP3%). The correlation coefficient R2 was 0.891. The cut-off
values of AHI 5/h, 15/h, and 30/h were used to extract the corresponding POB% values.
The obtained cut-off values were used to calculate the sensitivities, specificities and accuracies
of  the POB percentage to detect  patients  with the selected AHI values.  The sensitivity (0.948)
and specificity  (0.918) of  the POB percentage to find the patients  with AHI ≥ 15/h were both
excellent, and accuracy was a little lower (0.879). These numbers, with other sensitivities, speci-
ficities, and accuracies are presented in Table 9.
Table 9. The sensitivities, specificities and accuracies for the POB-parameter in
different AHI cut-off levels
AHI 5/h
 POB 9%
AHI 15/h
POB 21%
AHI 30/h
POB 39%
Sensitivity 0.766 0.948 0.935
Specificity 0.809 0.918 0.824
Accuracy 0.803 0.879 0.892
AHI = apnea-hypopnea index
POB% = percentage of combined obstructive periodic
breathing categories referred to total sleep time
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Based on the threshold definition (AHI ≥ 15/h), receiver operating characteristic (ROC) curve
was  derived  and  an  area  under  the  curve  (AUC)  was  calculated.  In  Figure  8,  the  ROC is  pre-
sented to reflect the diagnostic capability of the POB percentage when the AHI threshold is set
at AHI ≥ 15/h (means moderate disordered breathing). With this limit, the area under the curve
was 0.978. This means good accuracy, with 97.8% probability randomly chosen patient with
moderate sleep-disordered patients would be correctly identified as such and differentiate from
randomly chosen  healthy ones (AHI < 15/h). Chosen cut-off 21 for POB% gives sensitivity of
91.8% and specificity of 94.8%.
Figure 8. Receiver operating characteristic (ROC) curve reflecting the Emfit scoring limit
(POB%) for threshold AHI ≥ 15/h. Blue lines point sensitivity (91.8%) and specificity
(94.8%) to the chosen POB% cut-off 21%.
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6.3 Clinical evaluation of prolonged partial obstruction (Study III
and IV)
6.3.1 Prolonged partial obstruction among sleep laboratory patients (Study III)
In study III, the impact of prolonged partial obstruction on sleep quality and subjective sleepi-
ness  was  evaluated  among  157  sleep  laboratory  patients.  The  results  of  Emfit  scoring  of  the
patients are presented in Table 10.
Table 10. Percentages of time (referred to TST) spent in different Emfit categories
(n=157 patients).
Median Min Max
NB% 51.6 0.0 89.4
P1% 5.0 0.0 33.2
OP1% 11.3 0.0 95.9
OP2% 0.7 0.0 43.3
OP3% 0.0 0.0 36.3
CPB% 0.0 0.0 0.0
IRR% 3.5 0.0 55.3
M% 3.0 0.0 19.7
PM% 4.1 0.0 59.0
NB = normal breathing
P1 = periodic breathing type 1,
OP1 = obstructive periodic breathing type 1,
OP2 = obstructive periodic breathing type 2,
OP3 = obstructive periodic breathing type 3,
CPB = central periodic breathing,
IRR = increased respiratory resistance,
M = movement,
PM = periodic Movement
The cut-off value of AHI = 15/h and the IRR-percentage of 15% were utilized when the subjects
were  divided  into  four  groups.  Forty-seven  subjects  (=29.9%)  had  OSA  (AHI  ≥ 15/h,  IRR  <
15%, OSA+ -group). The IRR+ -group had 17 subjects (10.8%, AHI < 15/h, IRR ≥ 15%). The
OSA+IRR+ -group had 13 subjects (8.3%, AHI ≥ 15/h, IRR ≥ 15%). The OSA-IRR- -group
comprised 80 subjects (51.0%, AHI < 15/h, IRR < 15%). The sleep disorder end-diagnoses
based on polysomnography of the patients in the OSA-IRR- -group differed markedly. As in the
other groups, the first end-diagnose was always sleep disordered breathing. Therefore, the OSA-
IRR- -group was replaced with the group of 20 patients with mild OSA with no other sleep dis-
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6.3 Clinical evaluation of prolonged partial obstruction (Study III
and IV)
6.3.1 Prolonged partial obstruction among sleep laboratory patients (Study III)
In study III, the impact of prolonged partial obstruction on sleep quality and subjective sleepi-
ness  was  evaluated  among  157  sleep  laboratory  patients.  The  results  of  Emfit  scoring  of  the
patients are presented in Table 10.
Table 10. Percentages of time (referred to TST) spent in different Emfit categories
(n=157 patients).
Median Min Max
NB% 51.6 0.0 89.4
P1% 5.0 0.0 33.2
OP1% 11.3 0.0 95.9
OP2% 0.7 0.0 43.3
OP3% 0.0 0.0 36.3
CPB% 0.0 0.0 0.0
IRR% 3.5 0.0 55.3
M% 3.0 0.0 19.7
PM% 4.1 0.0 59.0
NB = normal breathing
P1 = periodic breathing type 1,
OP1 = obstructive periodic breathing type 1,
OP2 = obstructive periodic breathing type 2,
OP3 = obstructive periodic breathing type 3,
CPB = central periodic breathing,
IRR = increased respiratory resistance,
M = movement,
PM = periodic Movement
The cut-off value of AHI = 15/h and the IRR-percentage of 15% were utilized when the subjects
were  divided  into  four  groups.  Forty-seven  subjects  (=29.9%)  had  OSA  (AHI  ≥ 15/h,  IRR  <
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orders, (AHI 5-14.9/h, MildOSA-group). The demographic parameters and survey results of the
subjects in these groups are presented in Table 11.
Table 11. Demographic parameters and medication of the subjects in different groups.
OSA+
(n=47)
IRR+
(n=17)
OSA+IRR+
(n=13)
MildOSA
(n=20)
Age (years) 52 47 51 49
BMI1 (kg/m2) 28.1 30.0 31.0 26.0
ESS2 (score) 9 8 12 9
GHQ-123 (score) 2 8 2 3
SST (h) 4 7.0 7.8 6.0 5.8
Short-acting sleeping pill (%) 6.4 17.6 23.1 35.0
Benzodiazepine (%) 8.5 5.9 7.7 10.0
Antihypertensives (%) 36.2 23.5 38.5 20.0
Cholesterol drug (%) 12.8 11.8 23.1 10.0
Antidepressant (%) 19.1 17.6 15.4 25.0
1Body mass index
2Epworth sleepiness scale,
312-item General Health Questionnaire,
4Subjective sleep time
Further comparisons were performed between the OSA+ -group and the IRR+ -group (Table 12).
The scores of the ESS (Johns, 1991) questionnaire revealed that IRR-patients are as sleepy as
the OSA patients, but they had higher scores in the GHQ-12 questionnaire (Goldberg et al.,
1997). In addition, their objective sleep quality was better as indicated by a higher SWS per-
centage, a lower arousal index, and a lower PLM index. The AHI, ODI4, and SaO2minimum
percentage were higher in the OSA+ -group. The use of medications (presented in Table 11) did
not differ statistically between the groups.
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Table 12. Statistical comparisons of different parameters between the OSA+ and IRR+ groups.
OSA+
(n=47)
IRR+
(n=17) OSA+vs IRR+
ESS1 9 8 ns
GHQ-122 2 8 0.009
TST3 (h) 6.7 7.4 ns
SEI4 % 83.0 89.3 ns
SL5 (min) 13 15 ns
REMlat6 (min) 134.0 125.0 ns
%N17 9.3 5.8 ns
%N28 72.3 65.8 ns
%N39 3.0 9.1 0.005
%REM10 12.5 16.8 ns
ARI11 (n/h) 26.0 11.0 p<0.001
AHI12 (n/h) 33.2 7.7 p<0.001
ODI413 (%) 14.5 1.0 p<0.001
SaO2min14 (%) 84.0 87.0 p<0.001
Pulse (bpm) 61.0 60.7 ns
PLMI15 (n/h) 12.8 1.2 0.002
1Epworth sleepiness scale,
212-item General Health Questionnaire
3Total sleep time,
4Sleep efficiency index,
5Sleep latency,
6Latency to REM (rapid eye movement) sleep,
7-10Percentage of sleep stage (N1-REM) referred to TST,
11Arousal index, number of cortical arousals per hour of TST,
12Apnea-hypopnea index, apneas and hypopneas per hour of TST,
13Oxygen desaturation index, number of desaturations > 4% per hour of
TST,
14Minimum oxygen desaturation,
15Mean oxygen desaturation,
16Periodic limb movement index
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6.4 Evaluation of Emfit stages with HRV (Study IV)
The HRV parameters were calculated for sleep recordings of 53 subjects, and HRV parameters
for  the Emfit  breathing patterns NB, POB, and IRR were extracted.  In Figure 9a,  b,  and c  the
overnight trends of the HRV parameters from three SDB patients are illustrated. The time do-
main parameters are presented in Table 13 and Figure 10.  The meanRR of the breathing catego-
ries did not differ statistically. The standard deviation of normal-to-normal RR (SDNN) that
reflects overall HRV was higher during POB than during NB and IRR (p < 0.001). The minRR
was lower during the POB epochs than during NB and IRR (p < 0.001). The maxRR was lower
during IRR than during NB and POB (p < 0.001). The other comparisons did not show statisti-
cally significant differences.
Table 13. Time series measures of HRV (n = 53)
NB
mean ± SEM
POB
mean ± SEM
IRR
mean ± SEM
meanRR (ms) 1039.9 ± 22.2 1037.8 ± 22.3 1027.4 ± 22.6
minRR (ms) 783.4 ± 15.7 731.6 ± 15.7 810.7 ± 11.8
maxRR (ms) 1339.3 ± 35.4 1335.0 ± 30.4 1261.9 ± 33.6
SDNN (ms) 43.1 ± 3.1 59.7 ± 4.4 43.2 ± 3.3
HRV heart rate variability,
NB normal breathing,
POB periodic obstructive breathing,
IRR increased respiratory resistance,
meanRR, minRR, maxRR, SDNN = mean, minimum, maximum, and stand-
ard deviation of normal-to-normal RR intervals,
SEM = standard error of mean
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Figure 9a-c. Overnight trends of instantaneous RR-intervals (raw and filtered), and frequency
domain measurements (spectrogram, LF/HF ratio, LF and HF power bands). The colored bars
represent the different breathing categories (red = NB, blue = POB, green = IRR). Yellow bar =
REM-sleep. White areas = wakefulness which was not analyzed.
Figure 9a. Overnight HRV trends of a patient with mainly NB, few IRR periods.
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Figure 9b. Overnight HRV trends of a patient with both POB and IRR periods.
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Figure 9b. Overnight HRV trends of a patient with both POB and IRR periods.
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Figure 9c.  Overnight HRV trends of a patient with both NB and IRR periods.
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Figure 9c.  Overnight HRV trends of a patient with both NB and IRR periods.
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Figure 10. Time series of HRV. Mean, standard deviation, minimum and maximum of
normal-to-normal RR intervals (meanRR, SDNN, minRR and maxRR) during normal
breathing (NB), periodic obstructive breathing (POB), and increased respiratory re-
sistance (IRR). Mean values in milliseconds (ms) with standard error of mean (SEM) are
presented. The statistically significant differences are marked with lines.
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   VLF = Very low frequency power
   LF = Low frequency power
   HF = High frequency power
   Presented as Mean  ± SEM
   SEM = standard error of mean
Figure 11. Frequency domain results of HRV during normal breathing (NB), periodic ob-
structive breathing (POB), and increased respiratory resistance (IRR). The statistically signif-
icant differences are marked with lines.
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The HRV frequency domain results are presented in Table 14 and Figure 11. The total power,
VLF-power, and LF power were highest during POB, but the powers of NB and IRR did not
differ from each other. In the HF band, the power was lowest during NB, and the values of POB
and IRR did not differ. The LF/HF ratio was highest during POB and lowest during IRR.
Table 14. Frequency domain measures of HRV
NB
Mean ± SEM
POB
Mean ± SEM
IRR
Mean ± SEM
TPow(ms2) 2877.0 ± 389.5 6789.9 ± 974.1 2481.3 ± 371.0
VLF (ms2) 1097.5 ± 104.4 3259.6 ± 426.8 905.4 ± 96.2
LF (ms2) 866.6 ± 159.9 2099.5 ± 439.6 679.7 ± 141.4
HF (ms2) 928.4 ± 206.3 1263.1 ± 252.1 1113.8 ± 265.5
LF/HF 1.7 ± 0.2 3.0 ± 0.3 1.3 ± 0.1
NB normal breathing,
POB periodic obstructive breathing,
IRR increased respiratory resistance,
TPow = Total power,
VLF = Very low frequency power,
LF = Low frequency power,
HF= High frequency power,
SEM = standard error of mean
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6.5 Tracheal sound and prolonged partial obstruction (Studies I
and V)
6.5.1 Spectral analysis of the tracheal sound in the evaluation of flow limitation
pattern, Study I
The tracheal sound amplitudes during the three different breathing patterns derived from the
nasal pressure signal (normal breathing, episode with apneas/hypopneas, and flow limitation)
were extracted in Study 1. The sound amplitudes in 14 different frequency bands are presented
in Figure 12. The sound amplitude of normal breathing was the lowest in the 50-100 Hz band,
differing significantly from flow limitation and periodic breathing epochs that did not differ
from each other. The sound amplitudes of flow limitation epochs were the highest in all bands
above 100 Hz. The lowest amplitudes were found in normal breathing epochs in all bands ex-
cept the bands 601-700 Hz and 1001-2000 Hz, where the amplitudes of periodic breathing
epochs were also low and did not differ significantly from normal breathing (p-values were ≤
0.032 in all statistically significant comparisons).
Figure 12. The median tracheal sound amplitudes during 10-minute period of flow limitation,
normal breathing, and periodic breathing epochs in 14 frequency bands. The amplitudes are
presented in arbitrary units (au).
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In the further evaluation, the shares of the spectral components infrequency bands (50-100 Hz,
101-600 Hz, 1001-2000 Hz) were extracted for each breathing pattern. A large amount of nor-
mal breathing sound loudness was found in the lowest frequency band (62.4%, Figure 13). The
corresponding values of periodic breathing epochs and flow limitation epochs were 29.9% and
18.8%, respectively. All proportional amplitudes in the lowest band differed statistically from
each other (all p-values < 0.009). The flow limitation epochs presented the highest proportion
(64.9%) in the middle frequency band, where normal breathing presented the lowest proportion
(31.3%). The value of periodic breathing was 57.8%. In the middle frequency band, all values
differed statistically significantly (all p-values < 0.011). In the highest frequency band, the flow
limitation pattern presented the largest proportion (11.6%), differing significantly from the nor-
mal breathing (5.4%) and periodic breathing (10.6%, both p-values < 0.047), but there were no
other statistically significant differences in the highest band.
Figure 13. The percentage-proportions of the spectral components during the 10-minute periods
of the three breathing categories in the low (50-100 Hz), middle (101-600 Hz) and high (601-
5512 Hz) frequency bands. Median values across the patients are presented.
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6.5.2 Respiratory effort in the different compressed tracheal sound patterns
(Study V)
Ten-minute episodes of the compressed tracheal sound patterns (plain, thick, thin, Figure 4)
were selected in this work, where the earlier presented compressed tracheal sound patterns were
further studied (Rauhala et al., 2008). Sixteen subjects out of 27 had a 10-minute plain episode.
Nineteen subjects had a thick sound episode and another 19 subjects had at least one 10-minute
thin episode.
6.5.2.1 Esophageal pressure values in the compressed tracheal sound patterns
The esophageal pressure values were calculated for each compressed sound pattern. The result-
ing percentage of time with increased respiratory efforts (pESO ≤ -8 cmH2O) was highest dur-
ing the thin pattern (median 21.4%, range 3.5-31.9%), differing statistically significantly from
the plain sound pattern (0.03%, 0-1.0%, p = 0.01) and the thick pattern (9.6%, 3.9-20.1%, p =
0.002, Figure 14). During the plain sound pattern, the percentage was lowest and differed signif-
icantly from the thick pattern (p = 0.02).
Figure 14. Percentage values of pESO values ≤ -8 cmH2O during 10-minute episodes of differ-
ent compressed sound pattern.
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6.5.2.2 Spectral analysis of the raw tracheal sound signal during the different com-
pressed tracheal sound patterns
The tracheal sound amplitudes during the 10-minute compressed tracheal sound epochs in the
five frequency bands are presented in Figure 15. In all frequency bands, the amplitude was
highest during the thin pattern and lowest during the plain pattern (all p-values < 0.05).
The calculated percentage proportions of the spectral amplitudes during the 10-minute com-
pressed tracheal sound epochs in the five bands are presented in Figure 16. The thin pattern had
a lower percentage proportion value in the frequency band of 50-1000 Hz (median 81.1%, range
51.6-97.1%) than the thick pattern (90.6%, 53.0-96.5%, p= 0.02). The value of the plain pattern
was 93.8% (42.8-96.9%). In the frequency band of 1001-2000 Hz, the thin pattern had the high-
est percentage proportion value (9.7%, 1.2-17.7%), differing significantly from the plain pattern
(2.7%, 1.5-15.9%, p= 0.01) and the thick pattern (5.4%, 2.2-16.2%, p= 0.02). The difference
between the thick pattern and the plain pattern was also statistically significant (p= 0.02). The
three highest frequency bands showed no statistically significant differences.
Figure 15. Median tracheal sound amplitudes during the 10-minute compressed sound epochs
in the five frequency bands during the plain, thick, and thin sound patterns. The sound ampli-
tude was highest during the thin pattern and lowest during the plain pattern in all frequency
bands (all p-values < 0.05).
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Figure 16. The percentage proportions of the spectral components during the 10-minute com-
pressed tracheal sound epochs in the five frequency bands during the plain, thick, and thin
sound patterns. Median values are presented. The statistically significant differences are marked
with lines.
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7 Discussion
Different  sleep problems are common in public  health care.  As a  result,  there is  an increasing
need for quick and easy screening methods. Reliable and non-invasive methods are required to
distuinguish which problems need to be treated, because insufficient sleep leads to decreased
quality of life, work disability, and health problems such as insomnia, obesity, sleep apnea, and
cardivascular diseases.
For many years, the clinical work and quantification of SDB has been based on the calculation
of apnea-hypopnea index (AHI). However, the AHI index does not explain all patient symptoms,
as it does not take into account the different features of the respiratory events (Muraja-Murro et
al., 2014). Some clinical patients suffer from atypical sleep problems, but PSG gives low AHI
(Svensson et al., 2008). Often, these patients are left undiagnosed even if this patient group
might suffer from prolonged partial airway obstruction that can be treated with CPAP
(Anttalainen et al., 2010a, Anttalainen et al., 2013, Anttalainen et al., 2007a).
The SCSB mattress, as a forerunner, has long been used in sleep research to detect movements
and SDB, such as apneas and prolonged partial obstruction. Similar patterns can be observed
with the Emfit mattress that measures cardiorespiratory functions using ballistocardiography
(BCG). In clinical sleep, the Emfit signal can be used to detect periodic movements (Rauhala et
al., 2009). However, in the diagnostics of OSA and prolonged partial obstruction it has not been
validated. Preliminary reports suggest that prolonged partial obstruction could also be recorded
using tracheal sound measurement (Rauhala et al., 2008).
Even  if  prolonged  partial  obstruction  is  frequent  in  clinical  sleep  studies  (Anttalainen  et  al.,
2007a, Polo et al., 1988, Polo-Kantola et al., 2003), its impact on health and quality of life has
been a matter of lesser interest.  It has been reported that associations exist between asthma and
chronic obstructive pulmonary disease. In addition, women with prolonged partial obstruction
suffer less from hypertension than the general population (Anttalainen et al., 2010b).
The capability of the Emfit mattress to detect increased respiratory effort during sleep
That conventional AHI does not reflect the changes in intrathoracic pressure is a drawback in
diagnosing different SDB. Measuring intrathoracic pressure variation requires invasive catheter-
ization through the nostrils, which often is too complicated in clinical work and in the worst
case causes sleep fragmentation. Thus, other measuring methods are needed to improve the
accuracy of diagnostic procedures.
In an experimental study, SCSB high frequency spiking has been shown to evolve with
increased inspiratory resistance (Kirjavainen et al., 1996). When scoring is carried out visually
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case causes sleep fragmentation. Thus, other measuring methods are needed to improve the
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in clinical work,  SCSB and the Emfit signal comprise continuous high frequency spikes. To
evaluate whether the spikes in the Emfit breathing categories coincide with increased effort, the
intrathoracic pressure changes were evaluated in different Emfit breathing categories. Spikes
seem to reflect intrathoracic pressure variations because the esophageal pressure values de-
creased in the Emfit breathing categories where spikes emerged (OP 1-3, IRR). During NB and
P1 (without spikes), the pressure values remained more or less normal.
In this way, the Emfit mattress provides a noninvasive and patient-friendly tool to assess in-
trathoracic pressure variations. There are no restrictions or contraindications on the use of the
Emfit mattress. The Emfit film is a patented, Finnish-made commercially available material
(Emfit  Ltd).  Furthermore,  it  is  inexpensive  and  does  not  interfere  with  sleep  since  there  is  no
need to attach electrodes to the sleeper.
The Emfit mattress in OSA diagnostics
The respiratory scoring principles of the SCSB sensor have been reported by Polo and co-
workers (Polo, 1992) and the same principals have been adopted to Emfit scoring. Apneas can
be detected with SCSB, but the Emfit sensor has not been evaluated for the detection of apneas
before.
In detailed analysis of short Emfit breathing category periods, obstructive apneas, hypopneas,
arousals, and desaturations were generally abundant in the OP1, OP2, and OP3 categories. Dur-
ing NB and IRR, no apneas, hypopneas, arousals, or desaturations existed.
The correlation results showed that the longer the time spent with OP-patterns (POB), the great-
er the AHI values were. Whereas P1 and IRR showed no correlation to AHI, NB had clear nega-
tive correlation.  In clinical  practice,  the severity of  OSA is  expressed by AHI limits;  AHI < 5
(normal),  5  ≤ AHI < 15 (mild OSA),  15 ≤ AHI < 30 (moderate  OSA),  and AHI ≥ 30 (severe
OSA). Time percentages of POB representing the different AHI limits were extracted to ease
the clinical quantification of OSA detected by Emfit. The Emfit pattern scoring was found to
perform with excellent accuracy in detecting subjects with AHI 15/h or more. The correspond-
ing POB percentage limit for AHI 5/h was 9%, limits for AHI 15/h and 30/h were 21% and 39%,
respectively.
These results revealed the suitability of the Emfit sensor for OSA detection.  The easy and rapid
manual scoring procedure increases the attraction of using mattress sensors as a diagnostic tool
with large patient samples.
Clinical evaluation of prolonged partial obstruction
According to the presented results, OSA prevalence among sleep laboratory patients (mild +
severe OSA) was 43% and the prevalence of prolonged partial obstruction by Emfit scoring
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(IRR) was 11%. IRR was not found to be a rare phenomenon and it is quite surprising how few
of its symptoms and consequences have been examined.
When the IRR patients were compared with OSA patients they had fewer arousals and desatura-
tions, which correspond to the findings of the above mentioned 3-minute detailed Emfit breath-
ing  category  results.  Even  if  IRR  patients  had  more  deep  sleep  (SWS),  they  were  as  tired  as
OSA patients (ESS survey results). This might stem from the increased inspiratory efforts dur-
ing obstructive breathing that has been found to contribute to the subjective sleepiness (Pelin et
al., 2003).
OSA patients may also have atypical symptoms that include difficulty in falling asleep, frequent
awakenings, insomnia, and depression (Valipour et al., 2007). Women have been found to pre-
sent subjective symptoms with lower AHI than men (Young et al., 1993), and IRR has been
recognized more often among women (Anttalainen et al., 2007b). It might be that women suffer
both from mild OSA and IRR, and that the atypical symptoms arise because of IRR. This view
is  supported  by  the  fact  that  IRR  patients  had  increased  GHQ-12  score  in  the  present  study,
indicating more depressive mood and reduced quality of life.
Physiology of prolonged partial obstruction
OSA  is  a  well  recognized  risk  factor  for  cardiovascular  diseases  (McNicholas  &  Bonsigore,
2007). Yet, IRR has been associated with reduced prevalence of hypertension in females
(Anttalainen et al., 2010b). In addition, it has been found that mild stroke patients do not have
prolonged partial obstruction, though OSA was found to be common (prevalence 2.4% and
52.4%, respectively, (Väyrynen et al., 2014). The differences may be due to the different effects
OSA and IRR have on the autonomous nervous system (ANS). Patients with OSA have in-
creased sympathetic activity even when awake (Somers et al., 1995), but the interactions be-
tween prolonged partial obstruction and the ANS have not before been evaluated.
It was shown that periodic obstructive breathing (POB) induced a similar increase in sympathet-
ic activity as presented previously in sleep apnea (Somers et al., 1995).  This increase in sympa-
thetic activity was seen from the substantial heart rate variability during POB and the frequency
domain results of ECG. The total power, as well as the VLF, LF, and HF powers was high when
compared with normal breathing and the LF/HF ratio, which assesses sympathetic activity, had
clearly increased. Different physiological mechanisms behind the increase in sympathetic activi-
ty in POB are presented in Figure 17. The repetitive increases in negative intrathoracic pressure
in POB result in reduced cardiac output, which decreases baroreceptor firing and lead to an in-
crease in sympathetic activity and blood pressure (Bradley et al., 2001, Brinker et al., 1980,
Guilleminault et al., 1986, Morgan et al., 1966, Parker et al., 1999, Peters et al., 1988, Shiomi et
al., 1991, Tolle et al., 1983). Other mechanisms that are found to increase sympathetic activity
are hypoxia, hypercapnia, and arousals (Foster et al., 2009, Morgan et al., 1993, Ringler et al.,
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1990, Somers et al., 1989). In addition, hypoxia with arousal can induce an additive increase in
sympathetic activity (O'Donnell et al., 1996) and hypoxia may impair local vasodilatation
(Foster et al., 2009), thus increasing blood pressure.
Figure 17. Physiological effects of periodic obstructive breathing
During IRR, sympathetic activity decreased when compared with both NB and POB, and para-
sympathetic activity increased in IRR when compared with NB. Figure 18 presents the assumed
physiological processes in IRR. The intrathoracic pressure variations are supposed to induce a
similar increase in sympathetic activity in IRR as seen in POB. However, the effects of transient
desaturations and arousals do not emerge because they are not present in IRR. The shift of ANS
tone to parasympathetic dominance in IRR might be due to massive activation of the pulmonary
stretch  receptors  caused  by  the  increased  inspiratory  efforts  (Seals  et  al.,  1993).  Activation  of
the stretch receptors is known to inhibit the vasomotor area and sympathetic activity and leads
to vasodilatation of the resistance vessels, which decreases blood pressure.  In addition, the cu-
mulative increase in tcCO2 during IRR (Rauhala et al., 2007) may have an impact on vasomotor
activity by increasing local vasodilatation.
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Figure 18. Physiological effects of increased respiratory resistance
Partial obstruction is a common denominator for both IRR and UARS, but in UARS the ob-
structive episodes are short and repetitive and terminated by arousals (Guilleminault et al., 2005,
Poyares et al., 2002). In this respect, the physiological consequences of UARS and IRR can be
expected to differ.
There is one study that deals with HRV changes in UARS, but due to the methodological differ-
ences the results  are  not  comparable (Guilleminault  et  al.,  2005).  The use of  HRV analysis  in
SDB has been criticized because periodic apnea/hypopnea or UARS-like breathing with repeti-
tive arousals do not fulfill the requirements of signal stationarity (Stein & Pu, 2012). However,
the increase in sympathetic activity found in the present study is well documented using direct
measuring of nerve activity (Somers et al., 1995). Therefore, the findings in POB can be consid-
ered reliable. Because IRR presents regular breathing with no arousals and heart rate varies less
than during periodic breathing,  the IRR epochs that  were studied can be considered to fill  the
stationarity demands.
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Is IRR beneficial as it is associated with decreased sympathetic activity and the reduced preva-
lence in hypertension in females? This  seems to be implausible  because IRR is  found to coin-
cide with heavy snoring that is linked to carotid atherosclerosis (Lee et al., 2008). However, this
is possibly explained by the vibration-induced mechanical trauma on endothelium caused by
snoring. In addition, increased respiratory resistance has been reported to initiate an inflammato-
ry response with the elevation of plasma cytokines (Vassilakopoulos et al., 2004). The conse-
quences of endothelial dysfunction and inflammatory activation on the general health of IRR
patients have not been evaluated in detail. However, it may be that as the influence of IRR on
autonomous nervous activity is quite different from the effects of sleep apnea, the co-
morbidities may differ too. This needs to be further examined.
Tracheal sound and prolonged partial obstruction
In addition to Emfit, prolonged partial obstruction can appear as flow limitation in the nasal
pressure signal. It is not uncommon that prolonged flow limitation periods remain unnoticed in
clinical sleep recordings. However, the present study showed that prolonged flow limitation
episodes contained more high frequency components of the tracheal sound spectrum than peri-
odic breathing in every band over 100 Hz. It might stem from the fact that during flow limita-
tion  the  upper  airway  constriction  is  not  as  total  as  the  airway  closure  in  periodic  apnea-
hypopnea breathing. Presumably, airflow then reaches the mouth cavity and teeth, where more
high frequency sound components are produced, as in language production (Narayanan &
Alwan, 2000).
The analyzed tracheal sound results strengthen the view, that flow limitation represents obstruc-
tion because previously higher spectral values have been connected to upper airway obstruction
(Herzog et al., 2008, Kaniusas et al., 2005, Michael et al., 2008, Pasterkamp et al., 1997, Rao et
al., 1990, Yonemaru et al., 1993). So, it seems that flow limitation should be scored and diag-
nosed  from  sleep  studies.  However,  visual  detection  of  flow  limitation  from  nasal  prongs  is
quite laborious and therefore cumbersome to apply to clinical work. More importantly, factors
other than intrathoracic pressure can affect the flow contour (Condos et al., 1994). Moreover,
the recording sensor itself can induce an increase in respiratory resistance in patients with ana-
tomical variants such as deviated nasal septum or narrow nares (Lorino et al., 1998). In addition,
mouth breathing may disturb the contour of the airflow, and the displacement of prongs can
produce marked artifacts (Ballester et al., 1998). Therefore, other detection methods that cause
fewer disturbances are needed.
Compressed tracheal sound
In  the  present  study,  it  has  been  reported  that  Emfit  scoring  provides  reliable  means  to  detect
prolonged partial obstruction. However, there is an increased need for quicker and more unob-
trusive methods for SDB diagnostics. One such method is compressed tracheal sound analysis,
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as presented in this thesis. Compressed tracheal sound analysis has been shown to detect OSA
easily at a quick glance (Rauhala et al., 2008). In tracheal sound analysis three different respira-
tory patterns dominate: plain pattern, which seems to present normal breathing, thick pattern,
which has excellent correlation to AHI, and thin pattern, which is supposed to assess prolonged
partial obstruction. In the present study, intrathoracic pressure variations during 10-minute
compressed tracheal sound breathing patterns were studied with esophageal pressure monitoring.
The intrathoracic pressure increased during the thick and thin patterns suggesting increased
respiratory  resistance.  This  is  in  line  with  the  present  spectral  analysis  result  that  showed  an
increased share of higher frequencies of the tracheal sound signal during the thick and thin pat-
terns when compared with the plain pattern.
Many other screening devices can be used to distinguish apneas from normal breathing. This
work has succeeded in showing that the use of the compressed tracheal sound signal is an easy
and reliable method for screening not only apneas or hypopneas but also prolonged partial ob-
struction.
Mattress sensors in self-quantifying
Bio-hacking is nowadays a very popular business. The markets are full of health technology
products and mobile technology applications for self-quantifying. Memory capacities and data
transfer are no longer technical problems.  The Finnish companies (Emfit Ltd and Beddit Ltd)
have been pioneers in developing these new commercially available health technology products.
The quantification packages involved include sleep quality estimation, wellness information,
and provide every-day advice by automatically tracking sleeping patterns, heart rate, breathing,
snoring, and movements. Challenges appear when breathing, heart-beats or movements are not
normal i.e. if subject is suffering, for example, from SDB. Therefore, the proper validation of
the sensors that are targeted at the general public is important.
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Conclusions
This thesis  presents  that  Emfit  mattress  scoring can be used with great  accuracy in OSA diag-
nostics. In addition, this non-invasive technique assesses respiratory resistance related to partial
obstruction in adult patients. As a result, it is possible to assess intrathoracic pressure without
having to use an uncomfortable catheter and to disturb less the patients’ sleep. Revealing inspir-
atory effort improves the accuracy of SDB diagnostics, which helps medical personnel in deci-
sion-making and treatment selection.
Whereas Emfit scoring seems to be reliable in SDB diagnostics, the other conclusion of this
thesis is that compressed tracheal sound analysis presents a valid tool in SDB screening. Many
screening devices reveal OSA, but compressed tracheal sound analysis also indentifies pro-
longed partial obstruction. The small microphone used in the analysis is easy to wear and is
therefore quite suitable for ambulatory assessment of SDB. In addition, the analysis is quick and
easy, which enables its use in large patient samples.
Patients with prolonged partial obstruction are left untreated if AHI limits are used as treatment
criteria and, as a result, prolonged partial obstruction is left unnoticed. However, the present
thesis suggests that OSA and prolonged partial obstruction are quite different phenomena and
that prolonged partial obstruction also differs from normal breathing. These differences are
summarized in Table 15.
Table 15. Summary of findings in different SDB patterns in this thesis.
Normal
breathing
(NB)
Periodic breathing
(apnea /hypopnea)
Prolonged
partial
obstruction
Apneas/Hypopneas no yes no
Arousals no yes no
Desaturations no yes no
pESO increase no yes yes
High frequency components
in tracheal sound no yes yes
SDNN standard deviation of
normal-to-normal RR intervals
as compared with NB
increase no change
Sympathetic activity
as compared with NB increase decrease
Parasympathetic activity
as compared with NB increase increase
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Parasympathetic activity
as compared with NB increase increase
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